<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">98462</article-id>
<article-id pub-id-type="doi">10.7554/eLife.98462</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.98462.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology and Inflammation</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>T follicular helper cell profiles differ by malaria antigen and for children compared to adults</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7358-5546</contrib-id>
<name>
<surname>Forconi</surname>
<given-names>Catherine S.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nixon</surname>
<given-names>Christina</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Hannah W.</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Odwar</surname>
<given-names>Boaz</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pond-Tor</surname>
<given-names>Sunthorn</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ong’echa</surname>
<given-names>John M.</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1032-9558</contrib-id>
<name>
<surname>Kurtis</surname>
<given-names>Jonathan</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Moormann</surname>
<given-names>Ann M.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School</institution>, Worcester, MA, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Department of Pathology and Laboratory Medicine, Brown University</institution>, Providence, RI, <country>USA</country></aff>
<aff id="a3"><label>3</label><institution>Center for Global Health Research, Kenya Medical Research Institute</institution>, Kisumu, <country>Kenya</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Krzych</surname>
<given-names>Urszula</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Walter Reed Army Institute of Research</institution>
</institution-wrap>
<city>Silver Spring</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Rath</surname>
<given-names>Satyajit</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Indian Institute of Science Education and Research (IISER)</institution>
</institution-wrap>
<city>Pune</city>
<country>India</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Corresponding author Ann Moormann, PhD, MPH, FAAS, FASTMH Department of Medicine Division of Infectious Diseases and Immunology University of Massachusetts Chan Medical School 364 Plantation Street, LRB 313 Worcester, MA 01605 USA Office: 508-856-8826 (VoIP) Lab: 508-856-4562 Email: <email>ann.moormann@umassmed.edu</email></corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-06-21">
<day>21</day>
<month>06</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP98462</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-04-13">
<day>13</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-04-16">
<day>16</day>
<month>04</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.04.13.589352"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Forconi et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Forconi et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-98462-v1.pdf"/>
<abstract>
<title>Abstract</title>
<sec>
<title>Background</title>
<p>Circulating T-follicular helper (cT<sub>FH</sub>) cells have the potential to provide an additional correlate of protection against <italic>Plasmodium falciparum</italic> (<italic>Pf)</italic> as they are essential to promote B cell production of long-lasting antibodies. Assessing the specificity of cT<sub>FH</sub> subsets to individual malaria antigens is vital to understanding the variation observed in antibody responses and identifying promising malaria vaccine candidates.</p>
</sec>
<sec>
<title>Methods</title>
<p>Using spectral flow cytometry and unbiased clustering analysis we assessed antigen-specific cT<sub>FH</sub> cell recall responses <italic>in vitro</italic> to malaria vaccine candidates <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP within a cross-section of children and adults living in a malaria holoendemic region of western Kenya.</p>
</sec>
<sec>
<title>Findings</title>
<p>In children, a broad array of cT<sub>FH</sub> subsets (defined by cytokine and transcription factor expression) were reactive to both malaria antigens, <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP, while adults had a narrow profile centering on cT<sub>FH</sub>17- and cT<sub>FH</sub>1/17-like subsets following stimulation with <italic>Pf</italic>GARP only.</p>
</sec>
<sec>
<title>Interpretation</title>
<p>Because T<sub>FH</sub>17 cells are involved in the maintenance of memory antibody responses within the context of parasitic infections, our results suggest that <italic>Pf</italic>GARP might generate longer lived antibody responses compared to <italic>Pf</italic>SEA-1A. These findings have intriguing implications for evaluating malaria vaccine candidates as they highlight the importance of including cT<sub>FH</sub> profiles when assessing interdependent correlates of protective immunity.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>T-follicular-helper</kwd>
<kwd><italic>Pf</italic>-malaria</kwd>
<kwd>vaccine candidates</kwd>
<kwd>Kenya</kwd>
</kwd-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Despite progress made to reduce the global malaria burden, <italic>Plasmodium falciparum</italic> (<italic>Pf</italic>) remains one of the leading causes of mortality among children under 5 years of age (<xref ref-type="bibr" rid="c19">Geneva: World Health Organization, 2022</xref>). Unfortunately, progress has been impeded by a plateau in malaria control since 2015. Anti-malarial drug resistance (<xref ref-type="bibr" rid="c3">Aydemir et al., 2018</xref>; <xref ref-type="bibr" rid="c46">Taylor and Juliano, 2014</xref>), and unprecedented logistical challenges during the COVID-19 pandemic that dramatically impacted the distribution of insecticide-impregnated mosquito nets led to an increase in malaria cases in children under 5 years of age from 17.6 million in 2015 to 19.2 million in 2021 in East and Southern African countries (<xref ref-type="bibr" rid="c19">Geneva: World Health Organization, 2022</xref>; <xref ref-type="bibr" rid="c24">Ippolito et al., 2021</xref>), thus, contributing to reinvigorated prioritization of malaria vaccine initiatives.</p>
<p>After 30 years of development, the first malaria vaccine - RTS,S/AS01E - was approved by the World Health Organization in 2021 for use in children residing in malaria endemic regions. However, the limited efficacy of RTS,S (<xref ref-type="bibr" rid="c40">RTS,S Clinical Trials Partnership, 2015</xref>), particularly against severe malaria (<xref ref-type="bibr" rid="c40">RTS,S Clinical Trials Partnership, 2015</xref>) has motivated the search for additional vaccine candidate antigens including blood-stage <italic>Pf</italic>-schizont egress antigen-1 (<italic>Pf</italic>SEA-1A) (<xref ref-type="bibr" rid="c39">Raj et al., 2014</xref>) and <italic>Pf</italic>-glutamic acid-rich protein (<italic>Pf</italic>GARP) (<xref ref-type="bibr" rid="c38">Raj et al., 2020</xref>). Antibodies against <italic>Pf</italic>SEA-1A correlate with significantly lower parasite densities in Kenyan adults and adolescents, and substantially reduce schizont replication <italic>in vitro</italic> (<xref ref-type="bibr" rid="c29">Nixon et al., 2017</xref>; <xref ref-type="bibr" rid="c39">Raj et al., 2014</xref>). Whereas <italic>Pf</italic>GARP-specific antibodies kill trophozoite-infected erythrocytes in culture and confer partial protection against <italic>Pf</italic>-challenge in vaccinated non-human primates (<xref ref-type="bibr" rid="c38">Raj et al., 2020</xref>). The presence of antibodies against <italic>Pf</italic>GARP was associated with a 2-fold-lower parasite density in Kenyan adults and adolescents (<xref ref-type="bibr" rid="c38">Raj et al., 2020</xref>). Due to the complexity of the parasites’ life cycle, there is consensus that a multi-valent vaccine would prove to be more efficacious (<xref ref-type="bibr" rid="c23">Holder, 1999</xref>). However, determining which vaccine candidate antigens hold the most promise for inclusion in next-generation malaria vaccines remains a challenge.</p>
<p>Many pathogens and vaccines engender protective antibody responses after a single or few exposures (<xref ref-type="bibr" rid="c1">Amanna et al., 2007</xref>) characterized by the production of long-lived plasma cells and memory B cells (<xref ref-type="bibr" rid="c45">Tarlinton and Good-Jacobson, 2013</xref>). Affinity maturation takes place in the germinal center (GC) where not only antigen-specific CD4<sup>pos</sup> T-follicular helper (T<sub>FH</sub>) cells are required to provide cellular (CD40L) and molecular (IL21, IL4, IL13) signals to trigger B cell proliferation, promote GC maintenance and plasmablast differentiation, but where higher affinity B cells also out-compete B cells with lower affinity for T<sub>FH</sub> help (<xref ref-type="bibr" rid="c11">Crotty, 2019</xref>, <xref ref-type="bibr" rid="c12">2014</xref>). T<sub>FH</sub> cells are defined by the expression of a combination of markers, starting with chemokine receptor CXCR5 which directs CD4<sup>pos</sup> T cells from the T cell zone to engagement with follicular B cells (<xref ref-type="bibr" rid="c7">Breitfeld et al., 2000</xref>; <xref ref-type="bibr" rid="c13">Crotty, 2011</xref>). Once antigen-experienced T<sub>FH</sub> cells leave the GC, they become circulating T<sub>FH</sub> (cT<sub>FH</sub>) cells, and correlate with the generation of long-lasting antibody responses. Expression profiles of CCR6 and CXCR3 categorize cT<sub>FH</sub> subsets as follow: cT<sub>FH</sub>1 (CCR6<sup>neg</sup>CXCR3<sup>pos</sup>), cT<sub>FH</sub>2 (CCR6<sup>neg</sup>CXCR3<sup>neg</sup>) and cT<sub>FH</sub>17 (CCR6<sup>pos</sup>CXCR3<sup>neg</sup>) (<xref ref-type="bibr" rid="c42">Schmitt et al., 2014</xref>); whereas the expression of PD-1, ICOS, CD127 and CCR7 define their functional status: quiescent/central memory cT<sub>FH</sub> (CCR7<sup>high</sup>PD-1<sup>neg</sup>ICOS<sup>neg</sup>CD127<sup>pos</sup>) or activated/effector memory cT<sub>FH</sub> (CCR7<sup>low</sup>PD-1<sup>pos</sup>ICOS<sup>pos</sup>CD127<sup>low/neg</sup>) (<xref ref-type="bibr" rid="c16">Dunham et al., 2008</xref>; <xref ref-type="bibr" rid="c20">Gong et al., 2019</xref>; <xref ref-type="bibr" rid="c42">Schmitt et al., 2014</xref>). In addition, transcription factors (i.e., Bcl6 and cMAF) and cytokines (i.e., IFNγ, IL-4, and IL-21) are crucial to further characterizing the role of each cT<sub>FH</sub> subset within the context of their interactions with B cells to promote antibody production (<xref ref-type="bibr" rid="c2">Andris et al., 2017</xref>; <xref ref-type="bibr" rid="c4">Bélanger and Crotty, 2016</xref>; <xref ref-type="bibr" rid="c34">Olatunde et al., 2021</xref>; <xref ref-type="bibr" rid="c43">Seth and Craft, 2019</xref>). Bcl6 facilitates the production of IL-21 by T cells which aids B cell affinity maturation and antibody production (<xref ref-type="bibr" rid="c26">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="c31">Nurieva et al., 2009</xref>; <xref ref-type="bibr" rid="c30">Nurieva and Chung, 2010</xref>). T<sub>FH</sub> cells also secrete cytokines that align with their subset classifications (but are not limited to them), such as IFNγ (T<sub>FH</sub>1), IL-4/IL-13 (T<sub>FH</sub>2), IL-4/IL-5/IL-13 (T<sub>FH</sub>13), and IL-17 (T<sub>FH</sub>17) that direct antibody isotype class switching and mediate effector functions (<xref ref-type="bibr" rid="c4">Bélanger and Crotty, 2016</xref>; <xref ref-type="bibr" rid="c12">Crotty, 2014</xref>; <xref ref-type="bibr" rid="c20">Gong et al., 2019</xref>; <xref ref-type="bibr" rid="c21">Gowthaman et al., 2019</xref>; <xref ref-type="bibr" rid="c34">Olatunde et al., 2021</xref>; <xref ref-type="bibr" rid="c43">Seth and Craft, 2019</xref>).</p>
<p>Several studies have characterized cT<sub>FH</sub> subsets within the context of both adult and childhood <italic>Pf</italic>-malaria infections, as well as in healthy malaria-naïve volunteers under controlled malaria infection conditions (<xref ref-type="bibr" rid="c9">Chan et al., 2020</xref>). In Mali, where malaria is seasonal, Obeng-Adjei and colleagues showed that T<sub>H</sub>1-polarized cT<sub>FH</sub> PD1<sup>pos</sup>CXCR5<sup>pos</sup>CXCR3<sup>pos</sup> were preferentially activated in children, and were less efficient than the CXCR3<sup>neg</sup> cT<sub>FH</sub> in helping autologous B-cells produce antibodies; yet they used U.S. healthy adult cT<sub>FH</sub> cells for their <italic>in vitro</italic> assays. Therefore, the authors suggested that promoting Th2-like CXCR3<sup>neg</sup> cT<sub>FH</sub> subsets could improve antimalarial vaccine efficacy (<xref ref-type="bibr" rid="c32">Obeng-Adjei et al., 2015</xref>). Similarly, a recent study in Papua, Indonesia where malaria is perennial, found that all cT<sub>FH</sub> subsets from adults showed higher activation and proliferation compared to cT<sub>FH</sub> cells from children (<xref ref-type="bibr" rid="c35">Oyong et al., 2022</xref>). After <italic>in vitro</italic> stimulation with infected red blood cells, they found that all cT<sub>FH</sub> subsets were activated in adults accompanied by IL-4 production, whereas only the T<sub>H</sub>1-polarized cT<sub>FH</sub> subset responded in children (<xref ref-type="bibr" rid="c35">Oyong et al., 2022</xref>). One study in Uganda where malaria is holoendemic with seasonal peaks, was able to show that a shift from T<sub>H</sub>2-to T<sub>H</sub>1-polarized cT<sub>FH</sub> subsets occurred during the first 6 years of life, and was associated with the development of functional antibodies against <italic>Pf</italic>-malaria; yet appeared to be independent of malaria exposure as this age-associated shift was also observed in a malaria naïve population (<xref ref-type="bibr" rid="c10">Chan et al., 2022</xref>). Interestingly, this study also found that a higher proportion of T<sub>H</sub>17-cT<sub>FH</sub> cells was associated with a decreased risk of <italic>P. falciparum</italic> infection the following year, however the authors postulated that this phenomenon could have been driven by previous exposure to the parasite. The observed higher abundance of T<sub>H</sub>2-like cT<sub>FH</sub> cells in children younger than 6 years old and the age-associated increase in T<sub>H</sub>1-cT<sub>FH</sub> cells achieving the same proportion of T<sub>H</sub>1-cT<sub>FH</sub> cells by 6 years of age and into adulthood appeared to be independent of malaria exposure. Of note, these studies were limited by the use of a 2-dimensional gating strategy to classify cT<sub>FH</sub> subsets and whole parasite activation conditions, either during infections or <italic>in vitro</italic> stimulation assays, leaving the malaria-antigen specificity of the different cT<sub>FH</sub> subsets responses undefined. However, these studies highlight the progression in the field of evaluating the role of human T<sub>FH</sub> cells in anti-malarial immunity.</p>
<p>Antibody levels are an unreliable predictor of malaria vaccine efficacy (<xref ref-type="bibr" rid="c44">Stanisic and McCall, 2021</xref>). Thus, establishing a combined immune profile to incorporate other surrogates of protection is warranted. Here, we examined the profile of cT<sub>FH</sub> subsets using multiparameter spectral flow cytometry (<xref ref-type="bibr" rid="c5">Bentebibel et al., 2015</xref>; <xref ref-type="bibr" rid="c48">Wei et al., 2015</xref>) against two malaria vaccine candidate antigens (<italic>Pf</italic>SEA-1A (<xref ref-type="bibr" rid="c39">Raj et al., 2014</xref>) and <italic>Pf</italic>GARP (<xref ref-type="bibr" rid="c38">Raj et al., 2020</xref>)) in a cross-section of children and adults residing in a malaria holoendemic region of Kenya. Our findings revealed significant differences in cT<sub>FH</sub> subsets between children and adults, where children had more abundant cT<sub>FH</sub>1-like cells and showed antigen-specific responses from all cT<sub>FH</sub> types whereas these responses were limited to cT<sub>FH</sub>17- and 1/17-like in adults. Moreover, this study showed that <italic>Pf</italic>GARP triggered Bcl6 expression across cT<sub>FH</sub> subsets whereas <italic>Pf</italic>SEA-1A induced more cMAF expression, demonstrating the feasibility of implementing T cell immune correlates to down-select new malaria candidates.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Children had lower anti-PfSEA-1A antibodies compared to adults but similar levels of anti-PfGARP antibodies</title>
<p>This cross-sectional study selected a convenience sample of 7 years old children and adults with a mean age of 22.67 years (ranging from 19 to 30 years old). No statistical difference was observed (<italic>p</italic>=0.35 after Welch’s test) regarding the absolute lymphocyte count (ALC) between children (mean of 373.1; SD of 118.1) and adults (mean of 335.2; SD of 99.08). Children had significantly lower hematocrit (median of 37%, IQR of 32.7-40.5) compared to adults (median of 44.4%, IQR of 40.5-46), <italic>p=</italic>0.002 after a two-tailed Mann-Whitney t-test, however these values are within normal ranges adjusting for age.(Pluncevic Gligoroska et al., 2019) Both males and females (sex assigned at birth) were enrolled, with 43% (6/14) and 54% (8/15) being female within the children and adult groups, respectively. Seroprofiles against a panel of commonly used malaria antigens were generated to confirm the history of previous malaria infections for the selected children (<xref rid="fig1" ref-type="fig">Figure 1a</xref>). All participants had high IgG levels against AMA-1 and MSP1 (merozoite antigens), confirming at least one malaria infection within their lifetime (<xref ref-type="bibr" rid="c33">O’Flaherty et al., 2021</xref>; <xref ref-type="bibr" rid="c50">Yman et al., 2019</xref>). IgG antibodies against CSP and CelTOS (liver-stage antigens) were characteristically lower than against blood-stage antigens yet were present in all study children. We observed a clear bimodal distribution in antibody levels against HRP2 with half of the children having “high-HRP2” versus “low-HRP2” IgG levels, possibly a reflection of recent malaria history, since it has been suggested that HRP2-specific antibodies are short-lived and could serve as a surrogate for a recent infection (<xref ref-type="bibr" rid="c47">Turnbull et al., 2022</xref>). Serological profiles were then assessed for two <italic>Pf</italic>-malaria antigens being considered as potential vaccine candidates (<xref ref-type="bibr" rid="c38">Raj et al., 2020</xref>, <xref ref-type="bibr" rid="c39">2014</xref>), <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP (<xref rid="fig1" ref-type="fig">Figure 1b</xref>). We found that children had a significantly lower median level of IgG against <italic>Pf</italic>SEA-1A compared to adults (<italic>p</italic>&lt;0.0001), whereas median levels to <italic>Pf</italic>GARP were similarly high for adults and children, yet with a broad range of reactivity.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1:</label>
<caption><title><italic>Pf-</italic>malaria IgG sero-profiles for children and adults.</title>
<p><bold>(a)</bold> IgG antibody levels against AMA1, MSP1, HRP2, CelTos and CSP for children (n=14). The bar plots indicate mean with SD. (<bold>b)</bold> IgG antibody levels against <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP comparing children (n=15) and adults (n=15). The bar plots indicate mean with SD. Net MFI values are the antigen-specific MFI values minus the BSA background. Mann-Whitney tests were performed.</p></caption>
<graphic xlink:href="589352v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2b">
<title>The overall abundance of the CD4<sup>pos</sup>CXCR5<sup>pos</sup> cells is unaltered by in vitro antigen stimulation</title>
<p>To determine whether <italic>in vitro</italic> antigen stimulation with <italic>Pf</italic>SEA-1A or <italic>Pf</italic>GARP altered the abundance of total cT<sub>FH</sub> cells, we compared cT<sub>FH</sub> cells from adults and children using a FlowSOM unbiased clustering analysis and EMBEDSOM dimensional reduction based on common lineage markers assessed by spectral flow cytometry from 87,812 lived lymphocytes from each sample: CD8<sup>pos</sup>, CD4<sup>pos</sup>, CD4<sup>pos</sup>CXCR5<sup>pos</sup>, and CD4<sup>pos</sup>CD25<sup>pos</sup> (<xref rid="fig2" ref-type="fig">Figure 2a</xref>). As expected after a short stimulation (6 hrs), their overall abundances were similar across conditions for both adults (<xref rid="fig2" ref-type="fig">Figure 2b</xref>), and children (<xref rid="fig2" ref-type="fig">Figure 2c</xref>). This observation was confirmed by EdgeR statistical analysis (<xref rid="figs2" ref-type="fig">Supplemental Figure 2</xref>) and demonstrated that <italic>in vitro</italic> stimulation did not preferentially expand the T cell populations on which we based our subsequent analyses.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2:</label>
<caption><title>Clusters visualization of immune cell types and their abundance.</title>
<p><bold>(a)</bold> A 100 node and 75-meta-clusters FlowSOM tree was generated on live lymphocytes from all our participants (n=29 children and adults), highlighting CD3<sup>pos</sup>CD8<sup>pos</sup>, CD3<sup>pos</sup>CD4<sup>pos</sup>, CD4<sup>pos</sup>CXCR5<sup>pos</sup> and CD4<sup>pos</sup>CD25<sup>pos</sup> cells. The 5 nodes of the CD4<sup>pos</sup>CXCR5<sup>pos</sup>CD25<sup>neg</sup> population are circled and will be used for the downstream analysis. The colored scale was based on the median arcsinh-transformed marker expression. UMAP plots showing 5 clusters defined as follow: CD14/CD19<sup>pos</sup> (orange), CD4<sup>pos</sup> (blue), CD4<sup>pos</sup>CXCR5<sup>pos</sup> (red), CD8<sup>pos</sup> (purple) and CD4<sup>pos</sup>CD25<sup>pos</sup> (green) from <bold>(b)</bold> adults (n=15) <bold>(c)</bold> children (n=14) PBMCs after no-stimulation, <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP stimulation, respectively from left to right.</p></caption>
<graphic xlink:href="589352v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2c">
<title>An unbiased clustering analysis identifies twelve distinct cT<sub>FH</sub> meta-clusters</title>
<p>Numerous markers and a two-dimensional gating strategy have previously been used to determine the frequency of cT<sub>FH</sub> subsets (<xref ref-type="bibr" rid="c10">Chan et al., 2022</xref>; <xref ref-type="bibr" rid="c32">Obeng-Adjei et al., 2015</xref>; <xref ref-type="bibr" rid="c35">Oyong et al., 2022</xref>). To simultaneously account for the expression of 17 markers required to define cT<sub>FH</sub> subsets, we used FlowSOM unbiased clustering analysis to determine the frequency of cT<sub>FH</sub> subsets from a pool of 1,000 CD3<sup>pos</sup>CD4<sup>pos</sup>CXCR5<sup>pos</sup>CD25<sup>neg</sup> cells from each sample (total of 13,000 CD3<sup>pos</sup>CD4<sup>pos</sup>CXCR5<sup>pos</sup>CD25<sup>neg</sup> cells in both children and adult). Based on CXCR3 and CCR6 expression as well as the expression of effector/memory/activation markers (CCR7, CD127, PD1, ICOS), cytokines (IFNγ, IL-4, and IL-21) and transcription factors (Bcl6, cMAF), we initially identified 15 meta-clusters within the CD4<sup>pos</sup>CXCR5<sup>pos</sup> T cells (<xref rid="fig3" ref-type="fig">Figure 3a</xref>). First, we found different CXCR5 expression levels between meta-clusters (<xref rid="fig3" ref-type="fig">Figure 3b</xref>), suggesting different capabilities of cT<sub>FH</sub> to migrate to the lymph nodes and, therefore, to interact with B-cells, i.e., cT<sub>FH</sub> cells with lower CXCR5 expression would be less likely to reach the B-cell zone. Data presented in <xref rid="fig3" ref-type="fig">Figure 3</xref> are from children, however, similar observations were made for adults (<xref rid="figs3" ref-type="fig">Supplemental Figure 3</xref>). Because CD45RA<sup>pos</sup>CXCR5<sup>pos</sup> cells are likely naive cells with transient low expression of CXCR5 yet expressing high CD45RA, we excluded 3 meta-clusters using these criteria (i.e., MC12, MC14, and MC15) (<xref rid="fig3" ref-type="fig">Figure 3c</xref>). Then, using the overall expression of CXCR3 and CCR6 across the cT<sub>FH</sub> subsets (<xref rid="fig3" ref-type="fig">Figure 3d</xref> and <xref rid="fig3" ref-type="fig">3e</xref>), we identified the remaining 12 clusters as follows: MC01 and MC02 were cT<sub>FH</sub>2-like; MC06 and MC07 were cT<sub>FH</sub>1-like; MC09 and MC11 were cT<sub>FH</sub>1/17-like; MC10 and MC13 were cT<sub>FH</sub>17-like;. However, CXCR3 expression was not clearly delineated for some subsets and did not align with the conventional CCR6 vs CXCR3 cytoplot (<xref rid="fig3" ref-type="fig">Figure 3f</xref> and <xref rid="fig3" ref-type="fig">3g</xref>, <xref rid="figs4" ref-type="fig">Supplemental Figure 4</xref>). Based on the heatmap (<xref rid="fig3" ref-type="fig">Figure 3f</xref>), MC03, MC04, MC05 and MC08 clusters appear closer to cT<sub>FH</sub>2-like MC01 and MC02 than cT<sub>FH</sub>1-like clusters MC06 and MC07 suggesting that they might be part of the cT<sub>FH</sub>2-like subset. But, based on their intensity of CXCR3 expression and their distribution across the CCR6 vs CXCR3 cytoplot (<xref rid="figs4" ref-type="fig">Supplemental Figure 4</xref>) we defined MC03, MC04, MC05, MC08 as “undetermined” and would require additional cytokine and transcription factor characterization to fully categorize them.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3:</label>
<caption><title>Characterization of T<sub>FH</sub> subsets by CXCR5, CXCR3, CCR6 and CD45RA expression.</title>
<p><bold>(a)</bold> A new 25 nodes and 15 meta-clusters FlowSOM tree was generated from the 5 CD4<sup>pos</sup>CXCR5<sup>pos</sup>CD25<sup>neg</sup> nodes shown in <xref rid="fig2" ref-type="fig">Figure 2A</xref> (CXCR5 expression tree). The colored scale of CXCR5 expression was based on the median arcsinh-transformed with red as the highest and deep blue the absence of CXCR5 expression. <bold>(b)</bold> Box-plots showing CXCR5 expression across all cT<sub>FH</sub>-like meta-clusters from children (n=13) with no stimulation (blue), and after <italic>in vitro</italic> stimulation with <italic>Pf</italic>GARP (green) or <italic>Pf</italic>SEA-1A (pink). Fifty percent of the data points are within the box limits, the solid line indicates the median, the dash line the mean and the whiskers indicate the range of the remaining data with outliers being outside that range. Similar box-plots are shown for <bold>(c)</bold> CD45RA, <bold>(d)</bold> CXCR3, and <bold>(e)</bold> CCR6 expression across all cT<sub>FH</sub>-like meta-clusters. <bold>(f)</bold> Clustered heatmap showing the median arcsinh-transformed expression for CCR6, CD45RA, CXCR3 and CXCR5 across meta-clusters, red showing the highest expression and blue the lowest. <bold>(g)</bold> Cytoplots of CCR6 vs CXCR3 expression where MC01 is in blue, MC07 in pink, MC11 in yellow and MC13 in green.</p></caption>
<graphic xlink:href="589352v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>Heterogeneity of activation/maturation markers within cT<sub>FH</sub> subsets</title>
<p>By assessing the expression of CCR7, PD1, CD127, and ICOS (<xref rid="fig4" ref-type="fig">Figure 4</xref>) and following the three-dimensional expression patterns adapted from Schmitt et. al (<xref ref-type="bibr" rid="c42">Schmitt et al., 2014</xref>) (<xref rid="figs5" ref-type="fig">Supplemental Figure 5</xref>), we determined the activation state of each cT<sub>FH</sub> meta-cluster and which markers created novel subsets. Data represented in <xref rid="fig4" ref-type="fig">Figure 4</xref> are from children; however, similar observations were made for adults (<xref rid="figs6" ref-type="fig">Supplemental Figure 6</xref>). As expected, none of the extracellular markers showed significant differences in expression patterns after a short 6 hrs stimulation, thus representing the cT<sub>FH</sub> repertoire present within our study participants. Interestingly, the cT<sub>FH</sub>1or2 subset (MC03) was the only meta-cluster with high expression of PD1 (<xref rid="fig4" ref-type="fig">Figure 4a</xref>) and accompanied by high ICOS (<xref rid="fig4" ref-type="fig">Figure 4b</xref>), low CCR7 (<xref rid="fig4" ref-type="fig">Figure 4c</xref>), and low expression of CD127 (<xref rid="fig4" ref-type="fig">Figure 4d</xref>) suggesting that MC03 was an activated/effector cT<sub>FH</sub>1or2 subset. Low CCR7 and high ICOS but with low CD127 and PD1 expression indicated that MC04 was a less activated/effector cT<sub>FH</sub>1or2 subset compared to MC03. Additional nuances in expression pattern were also observed for other cT<sub>FH</sub>1-like meta-clusters: cT<sub>FH</sub>1-like MC06 had an activated/effector profile whereas cT<sub>FH</sub>1-like MC07 had a quiescent/effector profile; cT<sub>FH</sub>1or2-like MC05 and MC08 were defined as quiescent/memory (overall high CCR7 expression) yet with very low expression of ICOS for MC05. Likewise, cT<sub>FH</sub>2-like and cT<sub>FH</sub>17-like meta-clusters also displayed heterogeneity: cT<sub>FH</sub>2-like MC01 had an activated/effector profile whereas cT<sub>FH</sub>2-like MC02 seemed to be a quiescent/effector subset; cT<sub>FH</sub>1/17-like subsets MC09 and MC11 overall had an activated profile even though they had higher expression of CCR7 and CD127 compared to other subsets, suggesting an activated/memory phenotype; and finally cT<sub>FH</sub>17-like MC10 seemed quiescent whereas cT<sub>FH</sub>17-like MC13 had an activated/effector profile. Of note, because of our short stimulation time (6H) we were not able to assess CD40L expression (<xref rid="figs7" ref-type="fig">Supplemental Figure 7</xref>). However, our analysis methods revealed a higher degree of previously unrecognized heterogeneity within circulating cT<sub>FH</sub> cells.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4:</label>
<caption><title>cT<sub>FH</sub> subset activation state determined by PD1, ICOS, CCR7, and CD127.</title>
<p>Box-plots showing <bold>(a)</bold> PD1, <bold>(b)</bold> ICOS, <bold>(c)</bold> CCR7, and <bold>(d)</bold> CD127 expression across all cT<sub>FH</sub>-like meta-clusters from children (n=13) with no stimulation (blue), and after <italic>in vitro</italic> stimulation with <italic>Pf</italic>GARP (green) or <italic>Pf</italic>SEA-1A (pink). Fifty percent of the data points are within the box limits, the solid line indicates the median, the dash line the mean and the whiskers indicate the range of the remaining data with outliers being outside that range.</p></caption>
<graphic xlink:href="589352v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2e">
<title>Activated cT<sub>FH</sub>1or2-, cT<sub>FH</sub>1-, and quiescent cT<sub>FH</sub>1or2-like subsets were more abundant in children</title>
<p>After having deconvoluted cT<sub>FH</sub> cells into 12 subsets, we next wanted to determine whether their abundance differed by age or after antigen stimulation. Using UMAP visualization, we found that cT<sub>FH</sub> dimensional reduction was contiguous as meta-clusters merged with each other; in addition, there were notable differences between adults and children (<xref rid="fig5" ref-type="fig">Figure 5a</xref>). We found that activated PD1<sup>high</sup> cT<sub>FH</sub>1or2-like (MC03), activated cT<sub>FH</sub>1-like (MC06), and quiescent ICOS<sup>high</sup> cT<sub>FH</sub>1or2-like (MC08) subsets were significantly more abundant in children compared to adults regardless of the stimulation conditions (<xref rid="fig5" ref-type="fig">Figure 5b</xref>, 5c and 5d, <italic>p</italic>&lt;0.05). In contrast, quiescent cT<sub>FH</sub>2-like cells (MC02) were significantly more abundant in adults compared to children after both <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP stimulations (<xref rid="fig5" ref-type="fig">Figure 5c</xref> and <xref rid="fig5" ref-type="fig">5d</xref>, <italic>p</italic>&lt;0.05). Interestingly, following <italic>Pf</italic>GARP stimulation, the activated cT<sub>FH</sub>1/17-like subset MC09 became more abundant in children compared to adults (<xref rid="fig5" ref-type="fig">Figure 5d</xref><italic>, p</italic>&lt;0.05 with FDR=0.08); but no additional subsets expanded after <italic>Pf</italic>SEA-1A stimulation (<xref rid="fig5" ref-type="fig">Figure 5c</xref>). Of note, activated PD1<sup>low</sup> cT<sub>FH</sub>1or2-like (MC04) seemed more abundant in non-stimulated adults and <italic>Pf</italic>GARP stimulated children, but, because these observations were not present in all the participants, they did not achieve statistical significance in EdgeR.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5:</label>
<caption><title>Differences in abundance of antigen-specific cT<sub>FH</sub> meta-clusters for adults and children.</title>
<p><bold>(a)</bold> UMAP plots showing the 12 different cT<sub>FH</sub> meta-clusters in adults (top three plots, n=13) and in children (bottom three plots, n=13) in the absence of stimulation or after <italic>in vitro</italic> stimulation with <italic>Pf</italic>SEA-1A or <italic>Pf</italic>GARP, from left to right, respectively. Colored circles highlight the meta-clusters showing differences in their abundance between adults and children for each condition. An EdgeR statistical plot was performed to assess the change in abundance of the 12 meta-clusters between adults and children after <bold>(b)</bold> no stimulation, <bold>(c)</bold> <italic>Pf</italic>SEA-1A and <bold>(d)</bold> <italic>Pf</italic>GARP stimulations. EdgeR plots indicate which meta-clusters are significantly abundant between two groups by using green color dots. The Y-axis is the - log10(<italic>p</italic>-value) and the X-axis is the log(FC). Green dots were statistically significant (<italic>p</italic>&lt;0.05). Numbers next to the dots indicate the meta-cluster. <bold>(e)</bold> An abundance heatmap indicates the percentage (black numbers) of each meta-cluster within the total number of CD3<sup>pos</sup>CD4<sup>pos</sup>CXCR5<sup>pos</sup>CD25<sup>neg</sup> cells for adults and children (concatenated from 13 participants in each group) under the different conditions: no stimulation (Neg) or stimulation with <italic>Pf</italic>SEA-1A or <italic>Pf</italic>GARP. The color scale ranges from high expression (red) to low/no expression (blue). The star in the heatmap indicates which meta-cluster is significantly abundant in children or adults based on the EdgeR results.</p></caption>
<graphic xlink:href="589352v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>The abundance heatmap (<xref rid="fig5" ref-type="fig">Figure 5e</xref>) reiterates the differences observed between children and adults and highlights important considerations when assessing the potential role of each cT<sub>FH</sub> subsets in assisting with cognate antibody production. Overall, the most common cT<sub>FH</sub> subset in both children and adults is quiescent cT<sub>FH</sub>2-like cells (MC02, 24.1% and 41.2% respectively). However, the antigen-specific differences in cT<sub>FH</sub> subset abundance for children (MC09 for <italic>Pf</italic>GARP) and for adults (MC02 for both <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP) suggest that children engage different cT<sub>FH</sub> cells as they are developing immunity. Of note, only the activated PD1<sup>low</sup> cT<sub>FH</sub>1or2-like (MC04) was less abundant in children with low compared to high HRP2 antibody levels (<xref rid="figs8" ref-type="fig">Supplemental Figure 8</xref>), suggesting that this subset may be involved in short-term antibody production. Overall, this comprehensive examination of the abundance of cT<sub>FH</sub> subsets demonstrates important diversity based on age and malaria-antigen specificity.</p>
</sec>
<sec id="s2f">
<title>PfSEA-1A and PfGARP induced IL4, Bcl6 and cMAF from a broad range of cT<sub>FH</sub> subsets in children</title>
<p>Because the children in this cohort were 7 years of age and resided in a malaria holoendemic area, they had ample time to develop premunition. To assess antigen-specific cytokine and transcription factor expression signatures and further characterize cT<sub>FH</sub> subsets we generated clustered heatmaps of the MFI of each analyte (IFNγ, IL-4, IL-21, Bcl6 and cMAF) for children (<xref rid="figs9" ref-type="fig">Supplemental Figure 9a</xref>) and adults (<xref rid="figs9" ref-type="fig">Supplemental Figure 9b</xref>). Next, using these MFI data, we performed Wilcoxon paired tests to compare <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP stimulation to unstimulated cells (<xref rid="fig6" ref-type="fig">Figure 6a</xref> and <xref rid="fig6" ref-type="fig">6b</xref>, respectively). Significant differences in these expression profiles allowed us to further characterize meta-clusters into three main groups. Group 1: cT<sub>FH</sub>2-like (activated MC01 and quiescent MC02) and activated cT<sub>FH</sub>1or2-like (PD1<sup>high</sup>MC03 and PD1<sup>low</sup>MC04); Group 2: activated and quiescent cT<sub>FH</sub>1-like (MC06 and MC07); Group 3: activated cT<sub>FH</sub>1/17-like (MC11) and cT<sub>FH</sub>17-like (quiescent MC10 and activated MC13). For children, <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP induced robust IL4 expression in 9 out of 12 cT<sub>FH</sub> meta-clusters (<italic>p</italic>-values ≤ 0.0105); although the composition of which cT<sub>FH</sub> subsets were engaged differed slightly by antigen (quiescent cT<sub>FH</sub>1or2-like ICOS<sup>low</sup> MC05 versus quiescent cT<sub>FH</sub>2-like MC02, respectively). In contrast to IL-4, we observed no change in expression for IFNγ or IL-21 after <italic>in vitro</italic> antigen stimulation (except for quiescent cT<sub>FH</sub>1or2-like ICOS<sup>high</sup> MC08, <italic>p</italic>-value = 0.0391), suggesting these cytokines are not informative to define the development of antigen-specific cT<sub>FH</sub> subsets in children.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6:</label>
<caption><title>Diverse Pf-malaria antigen-specific expression patterns of cT<sub>FH</sub> defining cytokines and transcription factors for children.</title>
<p>Heatmaps of Wilcoxon-paired two-tailed t-test <italic>p</italic>-values are shown for cT<sub>FH</sub> meta-clusters comparing (a) <italic>Pf</italic>SEA-1A and (b) <italic>Pf</italic>-GARP versus unstimulated PBMCs from children (n=13) for each cytokine (IFNγ, IL4, and IL21) and transcription factor (Bcl6 and cMAF). The color-scale indicates the significance of the <italic>p</italic>-value: white (non-significant, <italic>p</italic>&gt;0.05), yellow (0.05&gt;<italic>p</italic>&gt;0.02), orange (0.02&gt;<italic>p</italic>&gt;0.005), and red (highly significant, <italic>p</italic>&lt;0.005). The down-directed arrow indicates a decrease of expression from unstimulated to stimulated condition whereas no arrow indicates an increase of expression from unstimulated to stimulated condition. The cT<sub>FH</sub> meta-clusters that co-expressed transcription factors were grouped as follows: Group 1 (blue line), Group 2 (green line), and Group 3 (purple line). Bar plots indicating mean with SD of the median intensity fluorescence (MFI) of <bold>(c)</bold> IFNγ, <bold>(d)</bold> Bcl6, and <bold>(e)</bold> cMAF for the cT<sub>FH</sub> meta-clusters showing significant statistical differences between <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP stimulations. <italic>p</italic>-values from Wilcoxon-paired two-tailed t-tests are indicated.</p></caption>
<graphic xlink:href="589352v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We found that <italic>Pf</italic>SEA-1A (<xref rid="fig6" ref-type="fig">Figure 6a</xref>) and <italic>Pf</italic>GARP (<xref rid="fig6" ref-type="fig">Figure 6b</xref>) induced similar Bcl6 and cMAF expression profiles from some of the same cT<sub>FH</sub> subsets: both transcription factors were expressed by activated cT<sub>FH</sub>2-like MC01 and quiescent cT<sub>FH</sub>17-like MC10, but only cMAF was expressed in activated and quiescent cT<sub>FH</sub>1-like MC06, MC07 and activated cT<sub>FH</sub>1/17-like MC11. However, <italic>Pf</italic>SEA-1A induced Bcl6 and cMAF from activated PD1<sup>high</sup>MC03 whereas <italic>Pf</italic>GARP only induced Bcl6. In contrast, quiescent cT<sub>FH</sub>2-like MC02 did not seem to respond to <italic>Pf</italic>SEA-1A (only cMAF was significant, <italic>p</italic>=0.0266, <xref rid="fig6" ref-type="fig">Figure 6a</xref>, <xref rid="figs10" ref-type="fig">Supplemental Figures 10</xref> and <xref rid="figs11" ref-type="fig">11</xref>), whereas <italic>Pf</italic>GARP stimulation induced significantly more IL-4, Bcl6, and cMAF compared to unstimulated cells (<italic>p</italic>=0.0081, <italic>p</italic>=0.0017, and <italic>p</italic>=0.0081, respectively, <xref rid="fig6" ref-type="fig">Figure 6b</xref>, <xref rid="figs10" ref-type="fig">Supplemental Figures 10</xref> and <xref rid="figs11" ref-type="fig">11</xref>). We then compared the response intensity between <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP stimulations, and found significant differences in IFNγ, IL21, Bcl6, and cMAF expression levels (<xref rid="fig6" ref-type="fig">Figure 6c</xref>, 6d, 6e and 6f, respectively). In Group 1, Bcl6 expression was significantly higher within activated and quiescent cT<sub>FH</sub>2-like (MC01 and MC02) as well as activated PD1<sup>high</sup> cT<sub>FH</sub>1or2-like (MC03) meta-clusters after <italic>Pf</italic>GARP compared to <italic>Pf</italic>SEA-1A stimulation (<italic>p</italic>=0.0266, <italic>p</italic>=0.0134 and <italic>p</italic>=0.0327, respectively, <xref rid="fig6" ref-type="fig">Figure 6e</xref>). Within Group 2, IFNγ and Bcl6 were found to be highly expressed by activated cT<sub>FH</sub>1-like (MC06) after <italic>Pf</italic>GARP compared to <italic>Pf</italic>SEA-1A stimulation (<italic>p</italic>=0.0093 and <italic>p</italic>=0.0024, respectively, <xref rid="fig6" ref-type="fig">Figure 6c</xref> and <xref rid="fig6" ref-type="fig">6e</xref>). Finally, within Group 3, activated cT<sub>FH</sub>1/17-like (MC11) expressed higher cMAF after <italic>Pf</italic>SEA-1A stimulation compared to <italic>Pf</italic>GARP (p=0.0186, <xref rid="fig6" ref-type="fig">Figure 6f</xref>). Interestingly, <italic>Pf</italic>GARP induced significantly more IL21 within the quiescent ICOS<sup>low</sup> cT<sub>FH</sub>1or2-like (MC05) meta-cluster compared to <italic>Pf</italic>SEA-1A stimulation (<italic>p</italic>=0.0186, <xref rid="fig6" ref-type="fig">Figure 6d</xref>). Non-significant differences in cytokines and transcription factors expressed by cT<sub>FH</sub> subsets between conditions are shown in <xref rid="figs12" ref-type="fig">Supplemental Figures 12</xref> and <xref rid="figs13" ref-type="fig">13</xref>, respectively.</p>
</sec>
<sec id="s2g">
<title>PfGARP induced IL4, Bcl6 and cMAF expression in activated cT<sub>FH</sub>1/17- and cT<sub>FH</sub>17-like subsets in adults</title>
<p>A similar heatmap was generated for adult expression profiles comparing <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP stimulation to unstimulated cells (<xref rid="fig7" ref-type="fig">Figure 7</xref>). Here, we found that both <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP induced significant expression of both IFNγ and IL-4 for activated (MC01) and quiescent (MC02) cT<sub>FH</sub>2-like cells (<xref rid="fig7" ref-type="fig">Figure 7a</xref> and <xref rid="fig7" ref-type="fig">7b</xref>, <xref rid="figs12" ref-type="fig">Supplemental Figure 12</xref>). Whereas, <italic>Pf</italic>GARP also induced IL-4 and IFNγ expression from quiescent and activated cT<sub>FH</sub>17-like (MC10 and MC13), in addition to Bcl6 and cMAF for MC13 (<xref rid="fig7" ref-type="fig">Figure 7b</xref>, <xref rid="figs13" ref-type="fig">Supplemental Figure 13</xref>). This observation was surprising because IFNγ-expression is commonly used to categorize the cT<sub>FH</sub>1 subset (Group 2); however, as shown earlier, quiescent and activated cT<sub>FH</sub>17-like (MC10 and MC13) did not express CXCR3 (<xref rid="fig3" ref-type="fig">Figure 3d</xref> and <xref rid="fig3" ref-type="fig">3e</xref>). In contrast, activated cT<sub>FH</sub>1/17-like (MC11) only responded to <italic>Pf</italic>GARP (<xref rid="fig7" ref-type="fig">Figure 7b</xref>, <xref rid="figs12" ref-type="fig">Supplemental Figure 12</xref>), expressing higher levels of IL-4, IL-21, Bcl6, and cMAF. Finally, while assessing the differences between the two malaria antigens, we found that <italic>Pf</italic>GARP induced more Bcl6 expression than <italic>Pf</italic>SEA-1A within quiescent cT<sub>FH</sub>2-like (MC02, <italic>p</italic>=0.0327) and quiescent ICOS<sup>low</sup> cT<sub>FH</sub>1or2-like (MC05, <italic>p</italic>=0.0105), as well as within quiescent cT<sub>FH</sub>17-like (MC10 <italic>p</italic>=0.0479) and activated cT<sub>FH</sub>1/17-like (MC11 <italic>p</italic>=0.0020) (<xref rid="fig7" ref-type="fig">Figure 7d</xref>), the latest expressing higher IL21 as well after <italic>Pf</italic>GARP compared to <italic>Pf</italic>SEA-1A stimulation (<italic>p</italic>=0.0273, <xref rid="fig7" ref-type="fig">Figure 7c</xref>); whereas <italic>Pf</italic>SEA-1A induced cMAF within activated cT<sub>FH</sub>2-like (MC01, <italic>p</italic>=0.0134) but <italic>Pf</italic>-GARP did not (<xref rid="fig7" ref-type="fig">Figure 7e</xref>). Overall, the main observation for adults is that <italic>Pf</italic>SEA-1A predominantly induced IL-4 from slightly more than half of the cT<sub>FH</sub> clusters, whereas <italic>Pf</italic>GARP induced a broader range of cytokines and transcription factors but within the activated cT<sub>FH</sub>1/17-like (MC11), quiescent and activated cT<sub>FH</sub>17-like (MC10 and MC13) similar to children. This analysis shows clear differences in cT<sub>FH</sub> subset specificity by malaria antigen and cT<sub>FH</sub> subset engagement by age group, with the cT<sub>FH</sub> repertoire becoming more restricted in adults compared to children.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7:</label>
<caption><title>Limited Pf-malaria antigen-specific expression patterns of cT<sub>FH</sub> defining cytokines and transcription factors for adults.</title>
<p>Heatmaps of Wilcoxon-paired two-tailed t-test <italic>p</italic>-values are shown for cT<sub>FH</sub> meta-clusters comparing (a) <italic>Pf</italic>SEA-1A or (b) <italic>Pf</italic>-GARP versus unstimulated PBMCs from adults (n=13) for each cytokine (IFNγ, IL4, and IL21) and transcription factors (Bcl6 and cMAF). The color-scale indicates the significance of the <italic>p</italic>-value: white (non-significant, <italic>p</italic>&gt;0.05), yellow (0.05&gt;<italic>p</italic>&gt;0.02), orange (0.02&gt;<italic>p</italic>&gt;0.005) and red (highly significant, <italic>p</italic>&lt;0.005). The down-directed arrow indicates a decrease of expression from unstimulated to stimulated condition whereas no arrow indicates an increase of expression from unstimulated to stimulated condition. The only cT<sub>FH</sub> meta-clusters that expressed transcription factors were in Group 3 (purple box). Bar plots indicating mean with SD of the median intensity fluorescence (MFI) of <bold>(c)</bold> Bcl6, and (<bold>d</bold>) cMAF for the cT<sub>FH</sub> meta-clusters showing significant statistical differences between <italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP stimulations. <italic>p</italic>-values from Wilcoxon-paired two-tailed t-tests are indicated.</p></caption>
<graphic xlink:href="589352v1_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2h">
<title>Activated cT<sub>FH</sub>1or2-like subset is more abundant in participants with high anti-PfGARP antibodies</title>
<p>As shown in <xref rid="fig1" ref-type="fig">Figure 1b</xref>, a broad range of anti-<italic>Pf</italic>GARP IgG antibody levels were found within both children and adults. Thus, we wanted to determine whether the abundance of any of the cT<sub>FH</sub> subsets was associated with the level of anti-<italic>Pf</italic>GARP IgG antibodies. When stratifying by high versus low anti-<italic>Pf</italic>GARP IgG antibody levels, we found that an activated cT<sub>FH</sub>1or2-like subset (MC04) was more abundant in participants with high levels of anti-<italic>Pf</italic>GARP IgG for both children (<xref rid="fig8" ref-type="fig">Figure 8a</xref>) and adults (<xref rid="fig8" ref-type="fig">Figure 8b</xref>) after <italic>Pf</italic>GARP stimulation compared to participants with low levels or an absence of anti-<italic>Pf</italic>GARP IgG. However, even though the <italic>p</italic>-values were significant for both children and adults (<italic>p</italic>=0.02 and <italic>p</italic>=0.004, respectively), the FDR was less than 0.05 only for the adults (FDR=0.018). This suggests that this particular subset might be important for the generation of anti-<italic>Pf</italic>GARP antibodies. Interestingly, activated cT<sub>FH</sub>1-like (MC06) and quiescent cT<sub>FH</sub>1-like (MC07) were more abundant for adults with low or no anti-<italic>Pf</italic>GARP IgG antibodies compared to those with high levels (<italic>p</italic>=0.0024 with FDR=0.0185 and <italic>p</italic>=0.0034 with FDR=0.0185, respectively) consistent with previous observations describing T<sub>FH</sub>1 subsets as not efficient help for antibody production (<xref ref-type="bibr" rid="c32">Obeng-Adjei et al., 2015</xref>).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8:</label>
<caption><title>Abundance of cT<sub>FH</sub> meta-clusters stratified by anti-PfGARP IgG antibody levels.</title>
<p>UMAP and EdgeR analysis of <bold>(a)</bold> children (n=13) and <bold>(b)</bold> adults (n=13) where significant differences (<italic>p</italic>&lt;0.05) in the abundance of the cT<sub>FH</sub> meta-clusters are circled on high versus low PfGARP antibody level (left to right) UMAP and green dots on the volcano plot (far right).</p></caption>
<graphic xlink:href="589352v1_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>The overall aim of this study was to define cT<sub>FH</sub> subsets using unbiased clustering analysis and assess their malaria antigen-specific (<italic>Pf</italic>SEA-1A and <italic>Pf</italic>GARP) (<xref ref-type="bibr" rid="c15">Duffy and Patrick Gorres, 2020</xref>; <xref ref-type="bibr" rid="c38">Raj et al., 2020</xref>, <xref ref-type="bibr" rid="c39">2014</xref>) profiles for adults and children residing in a malaria holoendemic area of Kenya. Contrary to previous publications (<xref ref-type="bibr" rid="c32">Obeng-Adjei et al., 2015</xref>; <xref ref-type="bibr" rid="c35">Oyong et al., 2022</xref>), our study found that children did not only respond via their cT<sub>FH</sub>1-like subsets but also engage a broader spectrum of cT<sub>FH</sub> subsets. In fact, cytokine and transcription factor profiles for children involved cT<sub>FH</sub>1-, cT<sub>FH</sub>2-, cT<sub>FH</sub>17- and cT<sub>FH</sub>1/17-like subsets (summarized in <xref rid="fig9" ref-type="fig">Figure 9</xref>) whereas in adults, the dominant antigen-specific memory response was from cT<sub>FH</sub>17- and cT<sub>FH</sub>1/17-like subsets but only for <italic>Pf</italic>GARP. Thus, revealing a potential difference in engaging cT<sub>FH</sub> help between the two malaria vaccine candidates evaluated in this study.</p>
<fig id="fig9" position="float" orientation="portrait" fig-type="figure">
<label>Figure 9:</label>
<caption><title>Summary.</title>
<p>Illustration of combined findings showing remarkable differences in cT<sub>FH</sub> subset abundance and <italic>Pf</italic>-malaria antigen-specific cytokine and transcription factor responses between children and adults residing in a malaria holoendemic region of Kenya. Made with BioRender.</p></caption>
<graphic xlink:href="589352v1_fig9.tif" mimetype="image" mime-subtype="tiff"/>
<permissions>
<copyright-statement>© 2024, BioRender Inc</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>BioRender Inc</copyright-holder>
<license><license-p>Any parts of this image created with <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link> are not made available under the same license as the Reviewed Preprint, and are © 2024, BioRender Inc.</license-p></license>
</permissions></fig>
<p>Several key points can be made from our results. First, it may be too soon in the field of cT<sub>FH</sub> biology to select only one or two types of cT<sub>FH</sub> subset(s) to measure when evaluating malaria vaccine candidates, especially if we miss essential, albeit transient, correlates of protection for children which may differ in adults. Longitudinal studies with clinical outcomes are needed to determine the impact of the changing dynamics of cT<sub>FH</sub> subset adaptations after repeated malaria infections that lead to premunition and parasite clearance. A Ugandan study by Chan et al (<xref ref-type="bibr" rid="c10">Chan et al., 2022</xref>) demonstrated an age-associated change in cT<sub>FH</sub> subsets independent of malaria and, thus, supports the importance of accounting for age when evaluating antigen-specific cT<sub>FH</sub> profiles. Second, our study reveals that adults have a robust cT<sub>FH</sub>17- and cT<sub>FH</sub>1/17-like subset response to <italic>Pf</italic>GARP but not to <italic>Pf</italic>SEA-1A. In addition to demonstrating differences between malaria antigens, this supports the premise that cT<sub>FH</sub>17 cells are important for maintaining immunological memory (<xref ref-type="bibr" rid="c18">Gao et al., 2023</xref>), which has intriguing implications for evaluating malaria vaccine efficacy. Third, we found a correlation between cT<sub>FH</sub>1or2-like (MC04) and high <italic>Pf</italic>GARP antibodies for both children and adults, indicating that a cT<sub>FH</sub> subset accompanied by high antibody levels could serve as a potential biomarker of protection. More studies are needed to explore this association; however, we postulate that a coalition of cT<sub>FH</sub> subsets might be engaged to develop long-lived antibody responses and, therefore, categorizing subsets as efficient or inefficient might be context dependent (<xref ref-type="bibr" rid="c32">Obeng-Adjei et al., 2015</xref>).</p>
<p>As the field of computational immunology and unbiased clustering analyses evolves, it presents an ongoing challenge to meaningfully define cT<sub>FH</sub> subsets. Here, we intentionally chose to use cT<sub>FH</sub>1or2-like nomenclature for meta-clusters MC03, MC04, MC05, and MC08 (<xref rid="fig9" ref-type="fig">Figure 9</xref>) because of their low CXCR3, but not null, and robust IL4 expression (instead of IFNγ along with Bcl6, and cMAF). CXCR3 expression leans towards a cT<sub>FH</sub>1-like polarization, whereas IL4 expression indicates a cT<sub>FH</sub>2-like profile when we follow the most commonly used cT<sub>FH</sub> classification (<xref ref-type="bibr" rid="c5">Bentebibel et al., 2015</xref>; <xref ref-type="bibr" rid="c34">Olatunde et al., 2021</xref>; <xref ref-type="bibr" rid="c42">Schmitt et al., 2014</xref>; <xref ref-type="bibr" rid="c43">Seth and Craft, 2019</xref>). This difference is crucial as cT<sub>FH</sub>2 cells are described as good promoters for functional GC antibodies (<xref ref-type="bibr" rid="c9">Chan et al., 2020</xref>; <xref ref-type="bibr" rid="c35">Oyong et al., 2022</xref>) whereas cT<sub>FH</sub>1 cells are not (<xref ref-type="bibr" rid="c22">Hansen et al., 2017</xref>; <xref ref-type="bibr" rid="c32">Obeng-Adjei et al., 2015</xref>; <xref ref-type="bibr" rid="c35">Oyong et al., 2022</xref>). Therefore, their definitive classification will require a more in depthr investigation. Even though we used malaria antigen-specific stimulation, and not a <italic>Pf</italic>-lysate or infected red blood cells (iRBCs) as previously described (<xref ref-type="bibr" rid="c10">Chan et al., 2022</xref>; <xref ref-type="bibr" rid="c32">Obeng-Adjei et al., 2015</xref>; <xref ref-type="bibr" rid="c35">Oyong et al., 2022</xref>), adults had significantly more of the quiescent cT<sub>FH</sub>2-like subset (MC02) compared to children who instead had significantly more of the activated cT<sub>FH</sub>1-like subset (MC06), the latest being consistent with previous publications (<xref ref-type="bibr" rid="c32">Obeng-Adjei et al., 2015</xref>; <xref ref-type="bibr" rid="c35">Oyong et al., 2022</xref>), and more PD1<sup>high</sup> activated and ICOS<sup>high</sup> quiescent cT<sub>FH</sub>1or2-like subsets (MC03 and MC08, respectively). However, even when classifying the cT<sub>FH</sub> meta-clusters as cT<sub>FH</sub>1, cT<sub>FH</sub>2, cT<sub>FH</sub>17, or cT<sub>FH</sub>1/17; the most abundant cT<sub>FH</sub> subset was cT<sub>FH</sub>2 cells for adults (more than 50%) contradicting a previous study showing only ∼20% of cT<sub>FH</sub>2 cells for the same age range (<xref ref-type="bibr" rid="c10">Chan et al., 2022</xref>) As suggested by Gowthaman’s T<sub>FH</sub> model (<xref ref-type="bibr" rid="c21">Gowthaman et al., 2019</xref>), T<sub>FH</sub>1 cells are involved in the development of neutralization antibody responses to viruses and bacteria whereas parasites, such as helminths, lead to a T<sub>FH</sub>2 response. These observations reinforce the need to assess T<sub>FH</sub> subset profiles stratified by exposure to potentially immune-modulating co-infections.</p>
<p>Transcription factors cMAF and Bcl6 play essential roles in T<sub>FH</sub> development and function (<xref ref-type="bibr" rid="c23a">Imbratta et al., 2020</xref>; <xref ref-type="bibr" rid="c27">Liu et al., 2012</xref>; <xref ref-type="bibr" rid="c31">Nurieva et al., 2009</xref>). cMAF induces the expression of various molecules, such as ICOS, PD1, CXCR5, IL4, and IL21, which are all essential for T<sub>FH</sub> function (<xref ref-type="bibr" rid="c23a">Imbratta et al., 2020</xref>). It was, therefore, not surprising to find that cMAF significantly increased after antigen stimulation for most of the cT<sub>FH</sub> subsets in children. However, again, this expression profile was only observed in the activated cT<sub>FH</sub>1/17-like subset (MC11) after <italic>Pf</italic>GARP stimulation in cells from adults, supporting a role for T<sub>FH</sub>17 cells in the maintenance of immunological memory (<xref ref-type="bibr" rid="c18">Gao et al., 2023</xref>). Importantly, cMAF cooperates with Bcl6 in T<sub>FH</sub> development and function and is essential to establish an efficient GC response (<xref ref-type="bibr" rid="c31">Nurieva et al., 2009</xref>; <xref ref-type="bibr" rid="c51">Yu et al., 2009</xref>). Bcl6 is also described as being expressed by mature T<sub>FH</sub> cells, inducing the expression of CXCR5 and PD1, but it can also regulate IFNγ and IL17 production (<xref ref-type="bibr" rid="c12">Crotty, 2014</xref>; <xref ref-type="bibr" rid="c25">Johnston et al., 2009</xref>; <xref ref-type="bibr" rid="c31">Nurieva et al., 2009</xref>; <xref ref-type="bibr" rid="c51">Yu et al., 2009</xref>). In our study, <italic>Pf</italic>GARP induced a highly significant increase of Bcl6 in cT<sub>FH</sub>2- like and cT<sub>FH</sub>17-like subsets in children, suggesting that <italic>Pf</italic>-GARP may be a better candidate to trigger an efficient humoral response in children compared to <italic>Pf</italic>SEA-1A. Of note, Blimp1, a Bcl6 antagonist (<xref ref-type="bibr" rid="c25">Johnston et al., 2009</xref>), was absent from our flow panel and would be of interest to assess in future studies.</p>
<p>There are several limitations of human immune profiling studies. Similar to other such studies, we used peripheral blood and, thus, were only able to provide a snapshot of the cT<sub>FH</sub> cells. Study participants did not have blood stage malaria infections at the time of blood collection and children were 7 years of age; thus, our profiles were by design meant to reflect cT<sub>FH</sub> memory recall responses and demonstrate differences between children and adults. As this was not a birth cohort study design, it is possible that the number of cumulative malaria infections could have confounded the association between malaria and cT<sub>FH</sub> subsets causing a certain cT<sub>FH</sub> meta-cluster to arise. Most human immunology studies are unable to assess tissue-resident T<sub>FH</sub> or T<sub>FH</sub> in the lymph nodes, and, therefore, we are only able to speculate on the composition of T<sub>FH</sub> cells observed in children that were perhaps short-lived helper and not maintained as T cell memory, or alternatively may have trafficked from the blood into tissues over time (<xref ref-type="bibr" rid="c37">Potter et al., 2021</xref>). Using an <italic>in vivo</italic> non-human primate model, Potter et al., showed an entry rate of lymphocyte subsets into peripheral lymph nodes per hour of 1.54% and 2.17% for CD4<sup>pos</sup> central memory (CD45<sup>neg</sup>CCR7<sup>pos</sup>) and effector memory (CD45<sup>neg</sup>CCR7<sup>neg</sup>) T cells, respectively (<xref ref-type="bibr" rid="c37">Potter et al., 2021</xref>), both of which may include central and effector memory cT<sub>FH</sub> cells. With this in mind, cT<sub>FH</sub> cells seem to be at a crossroad with multiple possible fates. The first one being the recirculation of cT<sub>FH</sub> cells from lymph node to lymph node whereby a peripheral blood sampling captures migratory cT<sub>FH</sub> subsets, which could explain the cT<sub>FH</sub> subsets we observed still expressing cMAF and Bcl6. A decade ago, it was hypothesized that once a T<sub>FH</sub> cell leaves the lymph node, it can become a PD1<sup>low</sup> memory cT<sub>FH</sub> cell with the possibility of returning to a germinal center T<sub>FH</sub> stage after a secondary recall response (<xref ref-type="bibr" rid="c12">Crotty, 2014</xref>). Other possible fates include becoming a PD1<sup>neg</sup> memory cT<sub>FH</sub> with the same path after recall or progressing to a non-T<sub>FH</sub> cell (<xref ref-type="bibr" rid="c12">Crotty, 2014</xref>). More recently, a few studies showed circulating CXCR5<sup>neg</sup>CD4<sup>pos</sup> cells with T<sub>FH</sub> functions, such as production of IL21 and the capability to help B cells in systemic lupus erythematosus and HIV-infected individuals (<xref ref-type="bibr" rid="c6">Bocharnikov et al., 2019</xref>; <xref ref-type="bibr" rid="c14">Del Alcazar et al., 2019</xref>), and importantly they mapped these circulating CXCR5<sup>neg</sup>CD4<sup>pos</sup> cells to an original lymph node CXCR5<sup>pos</sup> T<sub>FH</sub> subset (<xref ref-type="bibr" rid="c14">Del Alcazar et al., 2019</xref>), suggesting another possible outcome for T<sub>FH</sub> cells outside secondary lymphoid organs. To date, no clear destiny has been established for cT<sub>FH</sub> cells in humans, thus, highlighting the importance of including a complete panel of cT<sub>FH</sub> subsets to continue to improve our understanding of their respective roles against different pathogens and eliciting long-lived vaccine-induced antibody responses.</p>
<p>Other limitations of this study include not measuring other cytokines (i.e., IL5, IL13, IL17) and transcription factors (i.e., T-bet, BATF, GATA3, RORγt) that have been used in other studies to fully characterize cT<sub>FH</sub> subsets (<xref ref-type="bibr" rid="c12">Crotty, 2014</xref>; <xref ref-type="bibr" rid="c21">Gowthaman et al., 2019</xref>). However, even with our small sample size we demonstrated significant age-associated differences in malaria antigen-specific responses from different cT<sub>FH</sub> subsets. To minimize false positive results that can arise when using algorithms for computational analyses, we ran the statistical tests in triplicate and the clustering algorithm in duplicate, to validate our findings.</p>
<p>In summary, our study provides additional justification for the resources needed to conduct cellular immunological studies that include cT<sub>FH</sub> cell signatures and provides insight into which types of cT<sub>FH</sub> subset during a person’s lifespan assist germinal center B cells to produce long-lived plasmocytes and functional antibodies (<xref ref-type="bibr" rid="c28">Moormann et al., 2019</xref>) against malaria. This is particularly important when selecting immune correlates of protection that could be used to predict the efficacy of the next generation of <italic>Pf</italic>-malaria vaccine candidates within various study populations.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Study populations and ethical approvals</title>
<p>Adults and children were recruited from Kisumu County, Kenya which is holoendemic for <italic>Pf</italic>-malaria. Written informed consent was obtained from each adult participant and children guardian. An abbreviated medical history, physical examination, and blood film were used to ascertain health and malaria infection status at the time of blood sample collection. Participants were also life-long residents of the study area with an assumption that they naturally acquired immunity to malaria. This study was conducted prior to the implementation of any malaria vaccines. Participants were eligible if they were healthy and not experiencing any symptoms of malaria at the time venous blood was collected. For this cross-sectional immunology study, we selected fourteen 7-years old children from a larger age-structured prospective cohort study (enrollment age range 3-7 years) and fifteen Kenyan adults. We selected 7-year olds because of the age-dependent shift in major cT<sub>FH</sub> subsets occurring after 6-years of age (<xref ref-type="bibr" rid="c10">Chan et al., 2022</xref>), and as a comparable age published by other studies (<xref ref-type="bibr" rid="c32">Obeng-Adjei et al., 2015</xref>), in order to maximize our ability to measure antigen-specific differences in T<sub>FH</sub> subsets.</p>
<p>Ethical approvals were obtained from the Scientific and Ethics Review Unit (SERU) at the Kenya Medical Research Institute (KEMRI) reference number 3542, and the Institutional Review Board at the University of Massachusetts Chan Medical School, Worcester, MA, USA, IRB number H00014522. Brown University, Providence, RI, USA signed a reliance agreement with KEMRI.</p>
</sec>
<sec id="s4b">
<title>Plasma and PBMCs isolation</title>
<p>Venous blood was collected in sodium heparin BD Vacutainers and processed within 2 hours at the Center for Global Health Research, KEMRI, Kisumu. Absolute lymphocyte counts (ALC) were determined from whole blood using BC-3000 Plus Auto Hematology Analyzer, 19 parameters (Shenzhen Mindray Bio-Medical Electronics Co.). After 10 mins at 1,000g spin, plasma was removed and placed for storage at -20°C and an equivalent volume of 1X PBS was added to the cell pellet. Peripheral blood mononuclear cells (PBMCs) were then isolated using Ficoll-Hypaque density gradient centrifugation on SepMate (StemCell). PBMCs were frozen at 5x10<sup>6</sup> cells/ml in a freezing medium (90% heat-inactivated and filter-sterilized fetal bovine serum (FBS) and 10% dimethyl sulfoxide (Sigma)) and chilled overnight in Mr. Frosty™ containers at -80°C prior being transferred to liquid nitrogen. Transport to the USA used an MVE vapor shipper (MVE Biological Solutions) to maintain the cold chain.</p>
</sec>
<sec id="s4c">
<title>In-vitro stimulation assay</title>
<p>PBMCs were thawed in 37°C filtered-complete media (10% FBS, 2mM L-Glutamine, 10mM HEPES, 1X Penicillin/Streptomycin) and spun twice before resting overnight in a 37°C, 5% CO<sub>2</sub> incubator. PBMCs were counted using Trypan Blue (0.4%) and hemocytometer, and the cell survival was calculated. Our samples showed a median of 94.6% live cells [25% percentile of 92%; 75% percentile of 97%]. Using a P96 U-bottom plate, 1x10<sup>6</sup> PBMCs per well were placed in culture with one of the following stimulation conditions: <italic>Pf</italic>SEA-1A (<xref ref-type="bibr" rid="c39">Raj et al., 2014</xref>) (5 µg/ml) or <italic>Pf</italic>GARP (<xref ref-type="bibr" rid="c38">Raj et al., 2020</xref>) (10 µg/ml) both produced in the Kurtis lab (Brown University); SEB (1 µg/ml; EMD Millipore) as a positive control; sterile water (10µl, the same volume used to reconstitute <italic>Pf</italic>SEA and <italic>Pf</italic>GARP) as a negative control. A pool of anti-CD28/anti-CD49d (BD Fast-Immune Co-Stim following the manufacturer’s instructions), GolgiSTOP (0.7 µg/ml), and GolgiPLUG (0.1 µg/ml) (BD Biosciences) were added to each well before incubating cells at 37°C for 6-hours.</p>
</sec>
<sec id="s4d">
<title>Cell staining and Flow cytometry</title>
<p>A multiparameter spectral flow cytometry panel was used to characterize cT<sub>FH</sub> cell subsets: CCR6-BV421 (RRID: AB_2561356), CD14-Pacific Blue (RRID: AB_830689), CD19-Pacific Blue (RRID: AB_2073118), CCR7-BV480 (RRID: AB_2739502), IFNγ-BV510 (RRID: AB_2563883), CD127-BV570 (RRID: AB_10900064), CD45RA-BV605 (RRID: AB_2563814), PD1-BV650 (RRID: AB_2738746), CXCR3-BV711 (RRID: AB_2563533), CD25-BV750 (RRID: AB_2871896), CXCR5-BV785 (RRID: AB_2629528), Bcl6-AF488 (RRID: AB_10716202), CD3-Spark Blue 550 (RRID: AB_2819985), CD8-PerCP-Cy5.5 (RRID: AB_2044010), IL21-PE (RRID: AB_2249025), IL4-PE-Dazzle (RRID: AB_2564036), CD4-PE-Cy5 (RRID: AB_314078), ICOS-PE-Cy7 (RRID: AB_10643411), cMAF-eFluor 660 (RRID: AB_2574388), CD40L-AF700 (RRID: AB_2750053), and Zombie NIR (BioLegend cat# 423106) for Live/Dead staining. Data was acquired on a Cytek Aurora with 4-lasers (UMass Chan Flow Core Facility) using SpectroFlo® software (Cytek) and compensation for unmixing and fluorescence-minus-one controls. Quality control of the data was performed using SpectroFlo®, and the multi-parameter analysis was performed with OMIQ data analysis software (<ext-link ext-link-type="uri" xlink:href="http://www.omiq.ai">www.omiq.ai</ext-link>). Thus, we assessed the expression of markers commonly used to define the following different cT<sub>FH</sub> (CD4<sup>pos</sup>CD25<sup>neg</sup>CXCR5<sup>pos</sup>) subsets: cT<sub>FH</sub>1-like (CCR6<sup>neg</sup>CXCR3<sup>pos</sup>), cT<sub>FH</sub>2-like (CCR6<sup>neg</sup>CXCR3<sup>neg</sup>), and cT<sub>FH</sub>17-like (CCR6<sup>pos</sup>CXCR3<sup>neg</sup>) (<xref ref-type="bibr" rid="c42">Schmitt et al., 2014</xref>), as well as quiescent/central memory cT<sub>FH</sub> (CCR7<sup>high</sup>PD-1<sup>neg</sup>ICOS<sup>neg</sup>) or activated/effector memory cT<sub>FH</sub> cells (CCR7<sup>low</sup>PD-1<sup>pos</sup>ICOS<sup>pos</sup>) (<xref ref-type="bibr" rid="c20">Gong et al., 2019</xref>; <xref ref-type="bibr" rid="c42">Schmitt et al., 2014</xref>). Representative cytoplots can be found in <xref rid="figs1" ref-type="fig">Supplemental Figure 1</xref>.</p>
</sec>
<sec id="s4e">
<title>Multiplex suspension bead-based serology assay</title>
<p>To measure plasma IgG antibody levels to <italic>Pf</italic>SEA-1A (<xref ref-type="bibr" rid="c39">Raj et al., 2014</xref>) and <italic>Pf</italic>GARP (<xref ref-type="bibr" rid="c38">Raj et al., 2020</xref>), we used a Luminex bead-based suspension assay as previously published (<xref ref-type="bibr" rid="c8">Cham et al., 2009</xref>; <xref ref-type="bibr" rid="c17">Forconi et al., 2018</xref>). In addition, previous <italic>Pf</italic> exposure was determined using recombinant proteins to blood-stage malaria antigens: apical membrane antigen 1 (AMA1) and merozoite surface protein (MSP1), HRP2, CelTos, CSP (gifts from Sheetji Dutta, Evelina Angov, and Elke Bergmann from the Walter Reed Army Institute of Research). Briefly, 100μg of each antigen or BSA (Sigma), as a background control, were coupled to ∼12x10<sup>6</sup> non-magnetic microspheres (BioRad carboxylated beads) and then incubated with study participant plasma (spun down 10,000g for 10 mins and diluted at 1:100 in the assay dilution buffer) for 2 hrs, followed by incubation with biotinylated anti-human IgG (BD #555785) diluted 1:1000 for 1hr and streptavidin (BD #554061) diluted 1:1000 for 1 hr following the manufacturer’s instructions. The mean fluorescence intensity (MFI) of each conjugated bead (minimum of 50 beads per antigen) was quantified on a FlexMap3D Luminex multianalyte analyzer (Xponent software). Results are reported as antigen-specific MFI after subtracting the BSA value for each individual, since background levels can vary between individuals.</p>
</sec>
<sec id="s4f">
<title>OMIQ analysis</title>
<p>The fcs files were uploaded into the OMIQ platform after passing QC under SpectroFlo® (Cytek) where compensation was re-checked. In OMIQ, we arcsinh-transformed the scale to allow downstream analysis and then gated on singlet live lymphocytes and sub-sampled the data to yield 87,712 live lymphocytes per sample. Using only lineage markers CD3, CD4, CD8, CD14, CD19, CXCR5 and CD25, FlowSOM consensus meta-clustering was run on 100 clusters based on the 87,712 live lymphocytes per sample with a comma-separated k-value of 75, and Euclidean distance metric. Using these 75 meta-clusters, we defined subsets of cells based on lineage markers, such as CD3<sup>pos</sup>CD8<sup>pos</sup>, CD3<sup>neg</sup>CD14<sup>pos</sup>CD19<sup>pos</sup>, and CD3<sup>pos</sup>CD4<sup>pos</sup>, and then distinguished CD4<sup>pos</sup>CXCR5<sup>pos</sup>CD25<sup>neg</sup> (cT<sub>FH</sub>) and CD4<sup>pos</sup>CXCR5<sup>neg</sup>CD25<sup>pos</sup> (T regulatory [T<sub>reg</sub>] or T follicular regulatory [T<sub>FR</sub>]) subsets. CD25 was used to exclude T<sub>reg</sub> and T<sub>FR</sub> cells which share numerous markers with cT<sub>FH</sub> cells (<xref ref-type="bibr" rid="c41">Sage et al., 2014</xref>; <xref ref-type="bibr" rid="c49">Wing et al., 2018</xref>; <xref ref-type="bibr" rid="c52">Zhao et al., 2020</xref>). EmbedSOM dimensional reduction was used to visualize the different groups of cells and EdgeR analysis was run to assess the significance of their differences. A clustering heatmap was used to visualize cytokine expression and transcription factor profiles for each subset.</p>
<p>Focusing on the CD4<sup>pos</sup>CXCR5<sup>pos</sup>CD25<sup>neg</sup> T<sub>FH</sub> cells, we ran another FlowSOM analysis based on the 1,000 CXCR5<sup>pos</sup> cells per sample (two samples from the adult’s group and one sample from the children group were excluded from the analysis as they had less than 1,000 CXCR5<sup>pos</sup> cells), using extracellular markers CXCR5, CXCR3, CCR6, ICOS, CCR7, CD45RA, CD127, CD40L and PD1 allowing the identification of 15 meta-clusters. From there, we performed Uniform Manifold Approximation and Projection (UMAP) dimensional reduction, heatmaps, and EdgeR analyses, the latter allowing statistical analysis of the cT<sub>FH</sub> abundances. To demonstrate the reproducibility of these results, statistical analysis algorithms were run at least three times downstream of the same clustering algorithm and downstream of repeated clustering algorithms. To assess statistical differences in cytokines and transcription factor expression, we exported the statistics dataset from OMIQ containing MFI values from each marker (IFNγ, IL-4, IL-21, Bcl6 and cMAF) per cluster and for each sample and stimulation condition. To assess cytokines and transcription factors without bias, we chose to use the total MFI expression per meta-cluster with the assumption that cells with an increased production of the desire analyte will trigger an increase of the overall meta-cluster MFI compared to unstimulated cells, and if there is no production of the desire analyte, the overall MFI will not differ.</p>
</sec>
<sec id="s4g">
<title>Statistical analysis</title>
<p>For this cross-sectional immunology study, we selected both male and female, sex defined at birth, fourteen 7-year-old children and fifteen adults. Using GraphPad Prism software (version 7.0), age, sex, absolute lymphocyte count (ALC), and serological data were compared between adults and children. Because the number of participants within each group was too low to verify the normality of the underlying distributions (adults n=15 and children n=14), we chose to use non-parametric tests, including the Mann-Whitney U test (for unpaired analysis) and Wilcoxon signed-rank test (for paired analysis). When data passed the Normality test (D’Agostino and Pearson test), we used Welch’s parametric test. All tests were two-tailed with a <italic>p-value</italic> &lt; 0.05 for significance. Because of the exploratory nature of the analysis, we did not use any adjustment of the <italic>p</italic>-value for multiple comparisons. The tests used are indicated in the legend of each figure. Results were expressed using the mean with standard deviation for dot plots, and exact <italic>p</italic>-values.</p>
<p>To perform a statistical analysis of the cytokine and transcription factor expression from each cT<sub>FH</sub> subset, the exported data file from OMIQ was integrated into GraphPad Prism, and a non-parametric Wilcoxon paired-<italic>t-</italic>test, two-tailed, analysis was done (n=13 in each group). As this analysis generated numerous bar plots (all included in the <xref rid="figs12" ref-type="fig">supplemental figures 12</xref> to 15), in order to have a better visualization of the cytokines and transcription factors patterns, the <italic>p</italic>-values obtained from each analysis are presented using a non-clustering heatmap.</p>
</sec>
<sec id="s4h">
<title>Role of the funding source</title>
<p>Funders had no role in the study design; the collection of the samples, the analysis and the interpretation of the data as well as the writing of the manuscript and its decision to be submitted for publication.</p>
</sec>
</sec>
</body>
<back>
<sec id="s5">
<title>Contributors</title>
<p>CN, JMO, JK and AMM designed research study; CF and SPT conducted experiments; CF, JK and AMM analyzed data; CF, SPT, JK and AMM contributed to experimental design; HWW, BO, JMO, JK and AMM conducted and supervised the clinical study and the sampling; CF generated figures; HWW and BO verified underlying data; CF and AMM led manuscript preparation with feedback from all the authors. All authors have read and approved the final version of the manuscript.</p>
</sec>
<sec id="s6">
<title>Data Availability</title>
<p>Deidentified raw data from this manuscript are available from ImmPort platform under the accession study number SDY2534.</p>
</sec>
<sec id="s7">
<title>Declaration of Competing Interest</title>
<p>Dr Kurtis was the PI on 1R01AI127699-01A1 which supported this study. He holds several patents related to the use of <italic>Pf</italic>SEA-1 and <italic>Pf</italic>GARP as vaccine candidates for <italic>P. falciparum</italic> and has consulted for and is an equity holder in Ocean Biomedical.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to thank the children and their families for participating in this study. We thank the field and lab teams for their work collecting data and processing blood samples. We also thank Dr. Melanie Trombly from UMass Chan for proofreading our manuscript. This manuscript was approved for publication by the Kenya Medical Research Institute.</p>
<p>This study was supported by NIH R01 AI127699 (Kurtis).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Amanna</surname> <given-names>IJ</given-names></string-name>, <string-name><surname>Carlson</surname> <given-names>NE</given-names></string-name>, <string-name><surname>Slifka</surname> <given-names>MK</given-names></string-name>. <year>2007</year>. <article-title>Duration of humoral immunity to common viral and vaccine antigens</article-title>. <source>N Engl J Med</source> <volume>357</volume>:<fpage>1903</fpage>–<lpage>1915</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Andris</surname> <given-names>F</given-names></string-name>, <string-name><surname>Denanglaire</surname> <given-names>S</given-names></string-name>, <string-name><surname>Anciaux</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hercor</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hussein</surname> <given-names>H</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>O</given-names></string-name>. <year>2017</year>. <article-title>The Transcription Factor c-Maf Promotes the Differentiation of Follicular Helper T Cells</article-title>. <source>Front Immunol</source> <volume>8</volume>:<fpage>480</fpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Aydemir</surname> <given-names>O</given-names></string-name>, <string-name><surname>Janko</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hathaway</surname> <given-names>NJ</given-names></string-name>, <string-name><surname>Verity</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mwandagalirwa</surname> <given-names>MK</given-names></string-name>, <string-name><surname>Tshefu</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Tessema</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Marsh</surname> <given-names>PW</given-names></string-name>, <string-name><surname>Tran</surname> <given-names>A</given-names></string-name>, <string-name><surname>Reimonn</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ghani</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Ghansah</surname> <given-names>A</given-names></string-name>, <string-name><surname>Juliano</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Greenhouse</surname> <given-names>BR</given-names></string-name>, <string-name><surname>Emch</surname> <given-names>M</given-names></string-name>, <string-name><surname>Meshnick</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Bailey</surname> <given-names>JA</given-names></string-name>. <year>2018</year>. <article-title>Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes</article-title>. <source>J Infect Dis</source> <volume>218</volume>:<fpage>946</fpage>–<lpage>955</lpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Bélanger</surname> <given-names>S</given-names></string-name>, <string-name><surname>Crotty</surname> <given-names>S</given-names></string-name>. <year>2016</year>. <article-title>Dances with cytokines, featuring TFH cells</article-title>, <source>IL</source>-<volume>21</volume>, IL-4 and B cells. <italic>Nat Immunol</italic>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Bentebibel</surname> <given-names>S-E</given-names></string-name>, <string-name><surname>Jacquemin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Schmitt</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ueno</surname> <given-names>H</given-names></string-name>. <year>2015</year>. <article-title>Analysis of human blood memory T follicular helper subsets</article-title>. <source>Methods Mol Biol</source> <volume>1291</volume>:<fpage>187</fpage>–<lpage>197</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Bocharnikov</surname> <given-names>AV</given-names></string-name>, <string-name><surname>Keegan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wacleche</surname> <given-names>VS</given-names></string-name>, <string-name><surname>Cao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Fonseka</surname> <given-names>CY</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>G</given-names></string-name>, <string-name><surname>Muise</surname> <given-names>ES</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>KX</given-names></string-name>, <string-name><surname>Arazi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Keras</surname> <given-names>G</given-names></string-name>, <string-name><surname>Li</surname> <given-names>ZJ</given-names></string-name>, <string-name><surname>Qu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gurish</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Petri</surname> <given-names>M</given-names></string-name>, <string-name><surname>Buyon</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Putterman</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wofsy</surname> <given-names>D</given-names></string-name>, <string-name><surname>James</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Guthridge</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Diamond</surname> <given-names>B</given-names></string-name>, <string-name><surname>Anolik</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Mackey</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Alves</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Nigrovic</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Costenbader</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Brenner</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Lederer</surname> <given-names>JA</given-names></string-name>, <article-title>Rao DA, Accelerating Medicines Partnership (AMP) RA/SLE Network</article-title>. <year>2019</year>. <source>PD-1hiCXCR5-T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight</source> <volume>4</volume>. doi:<pub-id pub-id-type="doi">10.1172/jci.insight.130062</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Breitfeld</surname> <given-names>D</given-names></string-name>, <string-name><surname>Ohl</surname> <given-names>L</given-names></string-name>, <string-name><surname>Kremmer</surname> <given-names>E</given-names></string-name>, <string-name><surname>Ellwart</surname> <given-names>J</given-names></string-name>, <string-name><surname>Sallusto</surname> <given-names>F</given-names></string-name>, <string-name><surname>Lipp</surname> <given-names>M</given-names></string-name>, <string-name><surname>Förster</surname> <given-names>R</given-names></string-name>. <year>2000</year>. <article-title>Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production</article-title>. <source>J Exp Med</source> <volume>192</volume>:<fpage>1545</fpage>–<lpage>1552</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Cham</surname> <given-names>GKK</given-names></string-name>, <string-name><surname>Turner</surname> <given-names>L</given-names></string-name>, <string-name><surname>Lusingu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Vestergaard</surname> <given-names>L</given-names></string-name>, <string-name><surname>Mmbando</surname> <given-names>BP</given-names></string-name>, <string-name><surname>Kurtis</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Jensen</surname> <given-names>ATR</given-names></string-name>, <string-name><surname>Salanti</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lavstsen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Theander</surname> <given-names>TG</given-names></string-name>. <year>2009</year>. <article-title>Sequential, ordered acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 domains</article-title>. <source>J Immunol</source> <volume>183</volume>:<fpage>3356</fpage>–<lpage>3363</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Chan</surname> <given-names>J-A</given-names></string-name>, <string-name><surname>Loughland</surname> <given-names>JR</given-names></string-name>, <string-name><surname>de Labastida Rivera</surname> <given-names>F</given-names></string-name>, <string-name><surname>SheelaNair</surname> <given-names>A</given-names></string-name>, <string-name><surname>Andrew</surname> <given-names>DW</given-names></string-name>, <string-name><surname>Dooley</surname> <given-names>NL</given-names></string-name>, <string-name><surname>Wines</surname> <given-names>BD</given-names></string-name>, <string-name><surname>Amante</surname> <given-names>FH</given-names></string-name>, <string-name><surname>Webb</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hogarth</surname> <given-names>PM</given-names></string-name>, <string-name><surname>McCarthy</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Beeson</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Engwerda</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Boyle</surname> <given-names>MJ.</given-names></string-name> <year>2020</year>. <article-title>Th2-like T Follicular Helper Cells Promote Functional Antibody Production during Plasmodium falciparum Infection</article-title>. <source>Cell Rep Med</source> <volume>1</volume>:<fpage>100157</fpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Chan</surname> <given-names>J-A</given-names></string-name>, <string-name><surname>Loughland</surname> <given-names>JR</given-names></string-name>, <string-name><surname>de la Parte</surname> <given-names>L</given-names></string-name>, <string-name><surname>Okano</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ssewanyana</surname> <given-names>I</given-names></string-name>, <string-name><surname>Nalubega</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nankya</surname> <given-names>F</given-names></string-name>, <string-name><surname>Musinguzi</surname> <given-names>K</given-names></string-name>, <string-name><surname>Rek</surname> <given-names>J</given-names></string-name>, <string-name><surname>Arinaitwe</surname> <given-names>E</given-names></string-name>, <string-name><surname>Tipping</surname> <given-names>P</given-names></string-name>, <string-name><surname>Bourke</surname> <given-names>P</given-names></string-name>, <string-name><surname>Andrew</surname> <given-names>D</given-names></string-name>, <string-name><surname>Dooley</surname> <given-names>N</given-names></string-name>, <string-name><surname>SheelaNair</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wines</surname> <given-names>BD</given-names></string-name>, <string-name><surname>Hogarth</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Beeson</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Greenhouse</surname> <given-names>B</given-names></string-name>, <string-name><surname>Dorsey</surname> <given-names>G</given-names></string-name>, <string-name><surname>Kamya</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hartel</surname> <given-names>G</given-names></string-name>, <string-name><surname>Minigo</surname> <given-names>G</given-names></string-name>, <string-name><surname>Feeney</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jagannathan</surname> <given-names>P</given-names></string-name>, <string-name><surname>Boyle</surname> <given-names>MJ</given-names></string-name>. <year>2022</year>. <article-title>Age-dependent changes in circulating Tfh cells influence development of functional malaria antibodies in children</article-title>. <source>Nat Commun</source> <volume>13</volume>:<fpage>4159</fpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Crotty</surname> <given-names>S</given-names></string-name>. <year>2019</year>. <article-title>T Follicular Helper Cell Biology: A Decade of Discovery and Diseases</article-title>. <source>Immunity</source> <volume>50</volume>:<fpage>1132</fpage>–<lpage>1148</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Crotty</surname> <given-names>S</given-names></string-name>. <year>2014</year>. <article-title>T follicular helper cell differentiation, function, and roles in disease</article-title>. <source>Immunity</source> <volume>41</volume>:<fpage>529</fpage>–<lpage>542</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Crotty</surname> <given-names>S</given-names></string-name>. <year>2011</year>. <article-title>Follicular helper CD4 T cells (TFH)</article-title>. <source>Annu Rev Immunol</source> <volume>29</volume>:<fpage>621</fpage>–<lpage>663</lpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Del Alcazar</surname> <given-names>D</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>He</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wendel</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Del Río-Estrada</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ablanedo-Terrazas</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Malone</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Hernandez</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Frank</surname> <given-names>I</given-names></string-name>, <string-name><surname>Naji</surname> <given-names>A</given-names></string-name>, <string-name><surname>Reyes-Terán</surname> <given-names>G</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>N</given-names></string-name>, <string-name><surname>Su</surname> <given-names>LF</given-names></string-name>. <year>2019</year>. <article-title>Mapping the Lineage Relationship between CXCR5+ and CXCR5-CD4+ T Cells in HIV-Infected Human Lymph Nodes</article-title>. <source>Cell Rep</source> <volume>28</volume>:<fpage>3047</fpage>–<lpage>3060</lpage>.e7.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Duffy</surname> <given-names>PE</given-names></string-name>, <string-name><surname>Patrick Gorres</surname> <given-names>J</given-names></string-name>. <year>2020</year>. <article-title>Malaria vaccines since 2000: progress, priorities, products</article-title>. <source>NPJ Vaccines</source> <volume>5</volume>:<fpage>48</fpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Dunham</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Cervasi</surname> <given-names>B</given-names></string-name>, <string-name><surname>Brenchley</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Albrecht</surname> <given-names>H</given-names></string-name>, <string-name><surname>Weintrob</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sumpter</surname> <given-names>B</given-names></string-name>, <string-name><surname>Engram</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gordon</surname> <given-names>S</given-names></string-name>, <string-name><surname>Klatt</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Frank</surname> <given-names>I</given-names></string-name>, <string-name><surname>Sodora</surname> <given-names>DL</given-names></string-name>, <string-name><surname>Douek</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Paiardini</surname> <given-names>M</given-names></string-name>, <string-name><surname>Silvestri</surname> <given-names>G</given-names></string-name>. <year>2008</year>. <article-title>CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection</article-title>. <source>J Immunol</source> <volume>180</volume>:<fpage>5582</fpage>–<lpage>5592</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Forconi</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Cosgrove</surname> <given-names>CP</given-names></string-name>, <string-name><surname>Saikumar-Lakshmi</surname> <given-names>P</given-names></string-name>, <string-name><surname>Nixon</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Foley</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ong’echa</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Otieno</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Alter</surname> <given-names>G</given-names></string-name>, <string-name><surname>Münz</surname> <given-names>C</given-names></string-name>, <string-name><surname>Moormann</surname> <given-names>AM</given-names></string-name>. <year>2018</year>. <article-title>Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas</article-title>. <source>Blood Adv</source> <volume>2</volume>:<fpage>1101</fpage>–<lpage>1114</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Gao</surname> <given-names>X</given-names></string-name>, <string-name><surname>Luo</surname> <given-names>K</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Deng</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zeng</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Dong</surname> <given-names>X</given-names></string-name>, <string-name><surname>Xiong</surname> <given-names>L</given-names></string-name>, <string-name><surname>Gong</surname> <given-names>D</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>L</given-names></string-name>, <string-name><surname>Pohl</surname> <given-names>K</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Nguyen</surname> <given-names>THO</given-names></string-name>, <string-name><surname>Allen</surname> <given-names>LF</given-names></string-name>, <string-name><surname>Kedzierska</surname> <given-names>K</given-names></string-name>, <string-name><surname>Jin</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Du</surname> <given-names>M-R</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>W</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Shen</surname> <given-names>N</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Cockburn</surname> <given-names>IA</given-names></string-name>, <string-name><surname>Luo</surname> <given-names>W</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>D</given-names></string-name>. <year>2023</year>. <article-title>T follicular helper 17 (Tfh17) cells are superior for immunological memory maintenance</article-title>. <source>Elife</source> <volume>12</volume>. doi:<pub-id pub-id-type="doi">10.7554/eLife.82217</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="other"><collab>Geneva: World Health Organization</collab>. <year>2022</year>. <source>World malaria report 2022 (No. Licence: CC BY-NC-SA 3.0 IGO). WHO</source>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Gong</surname> <given-names>F</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>T</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>P</given-names></string-name>. <year>2019</year>. <article-title>T Follicular Helper Cell Subsets and the Associated Cytokine IL-21 in the Pathogenesis and Therapy of Asthma</article-title>. <source>Front Immunol</source> <volume>10</volume>:<fpage>2918</fpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Gowthaman</surname> <given-names>U</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>B</given-names></string-name>, <string-name><surname>Flynn</surname> <given-names>WF</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Song</surname> <given-names>W</given-names></string-name>, <string-name><surname>Joseph</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gertie</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Collet</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Grassmann</surname> <given-names>JDS</given-names></string-name>, <string-name><surname>Simoneau</surname> <given-names>T</given-names></string-name>, <string-name><surname>Chiang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Berin</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Craft</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Weinstein</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>A</given-names></string-name>, <string-name><surname>Eisenbarth</surname> <given-names>SC</given-names></string-name>. <year>2019</year>. <article-title>Identification of a T follicular helper cell subset that drives anaphylactic IgE</article-title>. <source>Science</source> <volume>365</volume>. doi:<pub-id pub-id-type="doi">10.1126/science.aaw6433</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Hansen</surname> <given-names>DS</given-names></string-name>, <string-name><surname>Obeng-Adjei</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ly</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ioannidis</surname> <given-names>LJ</given-names></string-name>, <string-name><surname>Crompton</surname> <given-names>PD</given-names></string-name>. <year>2017</year>. <article-title>Emerging concepts in T follicular helper cell responses to malaria</article-title>. <source>Int J Parasitol</source> <volume>47</volume>:<fpage>105</fpage>–<lpage>110</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Holder</surname> <given-names>AA</given-names></string-name>. <year>1999</year>. <article-title>Malaria vaccines</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>96</volume>:<fpage>1167</fpage>–<lpage>1169</lpage>.</mixed-citation></ref>
<ref id="c23a"><mixed-citation publication-type="journal"><string-name><surname>Imbratta</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hussein</surname> <given-names>H</given-names></string-name>, <string-name><surname>Andris</surname> <given-names>F</given-names></string-name>, <string-name><surname>Verdeil</surname> <given-names>G</given-names></string-name>. <year>2020</year>. <article-title>c-MAF, a Swiss Army Knife for Tolerance in Lymphocytes</article-title>. <source>Front Immunol</source> <volume>11</volume>:<fpage>206</fpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Ippolito</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Moser</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Kabuya</surname> <given-names>J-BB</given-names></string-name>, <string-name><surname>Cunningham</surname> <given-names>C</given-names></string-name>, <string-name><surname>Juliano</surname> <given-names>JJ</given-names></string-name>. <year>2021</year>. <article-title>Antimalarial Drug Resistance and Implications for the WHO Global Technical Strategy</article-title>. <source>Curr Epidemiol Rep</source> <volume>8</volume>:<fpage>46</fpage>–<lpage>62</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Johnston</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Poholek</surname> <given-names>AC</given-names></string-name>, <string-name><surname>DiToro</surname> <given-names>D</given-names></string-name>, <string-name><surname>Yusuf</surname> <given-names>I</given-names></string-name>, <string-name><surname>Eto</surname> <given-names>D</given-names></string-name>, <string-name><surname>Barnett</surname> <given-names>B</given-names></string-name>, <string-name><surname>Dent</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Craft</surname> <given-names>J</given-names></string-name>, <string-name><surname>Crotty</surname> <given-names>S</given-names></string-name>. <year>2009</year>. <article-title>Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation</article-title>. <source>Science</source> <volume>325</volume>:<fpage>1006</fpage>–<lpage>1010</lpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Nurieva</surname> <given-names>RI</given-names></string-name>, <string-name><surname>Dong</surname> <given-names>C</given-names></string-name>. <year>2013</year>. <article-title>Transcriptional regulation of follicular T-helper (Tfh) cells</article-title>. <source>Immunol Rev</source> <volume>252</volume>:<fpage>139</fpage>–<lpage>145</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Yan</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zhong</surname> <given-names>B</given-names></string-name>, <string-name><surname>Nurieva</surname> <given-names>RI</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Martin-Orozco</surname> <given-names>N</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Esplugues</surname> <given-names>E</given-names></string-name>, <string-name><surname>Flavell</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Tian</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Dong</surname> <given-names>C</given-names></string-name>. <year>2012</year>. <article-title>Bcl6 expression specifies the T follicular helper cell program in vivo</article-title>. <source>J Exp Med</source> <volume>209</volume>:<fpage>1841</fpage>–<lpage>52</lpage>, S1–24.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Moormann</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Nixon</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Forconi</surname> <given-names>CS</given-names></string-name>. <year>2019</year>. <article-title>Immune effector mechanisms in malaria: An update focusing on human immunity</article-title>. <source>Parasite Immunol</source> <volume>41</volume>:<fpage>e12628</fpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Nixon</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Park</surname> <given-names>S</given-names></string-name>, <string-name><surname>Pond-Tor</surname> <given-names>S</given-names></string-name>, <string-name><surname>Raj</surname> <given-names>D</given-names></string-name>, <string-name><surname>Lambert</surname> <given-names>LE</given-names></string-name>, <string-name><surname>Orr-Gonzalez</surname> <given-names>S</given-names></string-name>, <string-name><surname>Barnafo</surname> <given-names>EK</given-names></string-name>, <string-name><surname>Rausch</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Friedman</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Fried</surname> <given-names>M</given-names></string-name>, <string-name><surname>Duffy</surname> <given-names>PE</given-names></string-name>, <string-name><surname>Kurtis</surname> <given-names>JD</given-names></string-name>. <year>2017</year>. <article-title>Identification of Protective B-Cell Epitopes within the Novel Malaria Vaccine Candidate Plasmodium falciparum Schizont Egress Antigen 1</article-title>. <source>Clin Vaccine Immunol</source> <volume>24</volume>. doi:<pub-id pub-id-type="doi">10.1128/CVI.00068-17</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Nurieva</surname> <given-names>RI</given-names></string-name>, <string-name><surname>Chung</surname> <given-names>Y</given-names></string-name>. <year>2010</year>. <article-title>Understanding the development and function of T follicular helper cells</article-title>. <source>Cell Mol Immunol</source> <volume>7</volume>:<fpage>190</fpage>–<lpage>197</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Nurieva</surname> <given-names>RI</given-names></string-name>, <string-name><surname>Chung</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Martinez</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>XO</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>S</given-names></string-name>, <string-name><surname>Matskevitch</surname> <given-names>TD</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y-H</given-names></string-name>, <string-name><surname>Dong</surname> <given-names>C</given-names></string-name>. <year>2009</year>. <article-title>Bcl6 mediates the development of T follicular helper cells</article-title>. <source>Science</source> <volume>325</volume>:<fpage>1001</fpage>–<lpage>1005</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Obeng-Adjei</surname> <given-names>N</given-names></string-name>, <string-name><surname>Portugal</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tran</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Yazew</surname> <given-names>TB</given-names></string-name>, <string-name><surname>Skinner</surname> <given-names>J</given-names></string-name>, <string-name><surname>Li</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jain</surname> <given-names>A</given-names></string-name>, <string-name><surname>Felgner</surname> <given-names>PL</given-names></string-name>, <string-name><surname>Doumbo</surname> <given-names>OK</given-names></string-name>, <string-name><surname>Kayentao</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ongoiba</surname> <given-names>A</given-names></string-name>, <string-name><surname>Traore</surname> <given-names>B</given-names></string-name>, <string-name><surname>Crompton</surname> <given-names>PD</given-names></string-name>. <year>2015</year>. <article-title>Circulating Th1-Cell-type Tfh Cells that Exhibit Impaired B Cell Help Are Preferentially Activated during Acute Malaria in Children</article-title>. <source>Cell Rep</source> <volume>13</volume>:<fpage>425</fpage>–<lpage>439</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>O’Flaherty</surname> <given-names>K</given-names></string-name>, <string-name><surname>Oo</surname> <given-names>WH</given-names></string-name>, <string-name><surname>Zaloumis</surname> <given-names>SG</given-names></string-name>, <string-name><surname>Cutts</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Aung</surname> <given-names>KZ</given-names></string-name>, <string-name><surname>Thein</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Drew</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Razook</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Barry</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Parischa</surname> <given-names>N</given-names></string-name>, <string-name><surname>Zaw</surname> <given-names>NN</given-names></string-name>, <string-name><surname>Thu</surname> <given-names>HK</given-names></string-name>, <string-name><surname>Thi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Htay</surname> <given-names>WYM</given-names></string-name>, <string-name><surname>Soe</surname> <given-names>AP</given-names></string-name>, <string-name><surname>Simpson</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Beeson</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Agius</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Fowkes</surname> <given-names>FJI</given-names></string-name>. <year>2021</year>. <article-title>Community-based molecular and serological surveillance of subclinical malaria in Myanmar</article-title>. <source>BMC Med</source> <volume>19</volume>:<fpage>121</fpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Olatunde</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Hale</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Lamb</surname> <given-names>TJ</given-names></string-name>. <year>2021</year>. <article-title>Cytokine-skewed Tfh cells: functional consequences for B cell help</article-title>. <source>Trends Immunol</source> <volume>42</volume>:<fpage>536</fpage>–<lpage>550</lpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Oyong</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Loughland</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Soon</surname> <given-names>MSF</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>J-A</given-names></string-name>, <string-name><surname>Andrew</surname> <given-names>D</given-names></string-name>, <string-name><surname>Wines</surname> <given-names>BD</given-names></string-name>, <string-name><surname>Hogarth</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Olver</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Collinge</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Varelias</surname> <given-names>A</given-names></string-name>, <string-name><surname>Beeson</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Kenangalem</surname> <given-names>E</given-names></string-name>, <string-name><surname>Price</surname> <given-names>RN</given-names></string-name>, <string-name><surname>Anstey</surname> <given-names>NM</given-names></string-name>, <string-name><surname>Minigo</surname> <given-names>G</given-names></string-name>, <string-name><surname>Boyle</surname> <given-names>MJ</given-names></string-name>. <year>2022</year>. <article-title>Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children</article-title>. <source>EBioMedicine</source> <volume>75</volume>:<fpage>103784</fpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><given-names>Pluncevic</given-names> <surname>Gligoroska J</surname></string-name>, <string-name><surname>Gontarev</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dejanova</surname> <given-names>B</given-names></string-name>, <string-name><surname>Todorovska</surname> <given-names>L</given-names></string-name>, <string-name><surname>Shukova Stojmanova</surname> <given-names>D</given-names></string-name>, <string-name><surname>Manchevska</surname> <given-names>S</given-names></string-name>. <year>2019</year>. <article-title>Red Blood Cell Variables in Children and Adolescents regarding the Age and Sex</article-title>. <source>Iran J Public Health</source> <volume>48</volume>:<fpage>704</fpage>–<lpage>712</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Potter</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Gideon</surname> <given-names>HP</given-names></string-name>, <string-name><surname>Tkachev</surname> <given-names>V</given-names></string-name>, <string-name><surname>Fabozzi</surname> <given-names>G</given-names></string-name>, <string-name><surname>Chassiakos</surname> <given-names>A</given-names></string-name>, <string-name><surname>Petrovas</surname> <given-names>C</given-names></string-name>, <string-name><surname>Darrah</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>PL</given-names></string-name>, <string-name><surname>Foulds</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Kean</surname> <given-names>LS</given-names></string-name>, <string-name><surname>Flynn</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Roederer</surname> <given-names>M</given-names></string-name>. <year>2021</year>. <article-title>Measurement of leukocyte trafficking kinetics in macaques by serial intravascular staining</article-title>. <source>Sci Transl Med</source> <volume>13</volume>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.abb4582</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Raj</surname> <given-names>DK</given-names></string-name>, <string-name><surname>Das Mohapatra</surname> <given-names>A</given-names></string-name>, <string-name><surname>Jnawali</surname> <given-names>A</given-names></string-name>, <string-name><surname>Zuromski</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jha</surname> <given-names>A</given-names></string-name>, <string-name><surname>Cham-Kpu</surname> <given-names>G</given-names></string-name>, <string-name><surname>Sherman</surname> <given-names>B</given-names></string-name>, <string-name><surname>Rudlaff</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Nixon</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Hilton</surname> <given-names>N</given-names></string-name>, <string-name><surname>Oleinikov</surname> <given-names>AV</given-names></string-name>, <string-name><surname>Chesnokov</surname> <given-names>O</given-names></string-name>, <string-name><surname>Merritt</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pond-Tor</surname> <given-names>S</given-names></string-name>, <string-name><surname>Burns</surname> <given-names>L</given-names></string-name>, <string-name><surname>Jolly</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ben Mamoun</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kabyemela</surname> <given-names>E</given-names></string-name>, <string-name><surname>Muehlenbachs</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lambert</surname> <given-names>L</given-names></string-name>, <string-name><surname>Orr-Gonzalez</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gnädig</surname> <given-names>NF</given-names></string-name>, <string-name><surname>Fidock</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Park</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dvorin</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Pardi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Weissman</surname> <given-names>D</given-names></string-name>, <string-name><surname>Mui</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Tam</surname> <given-names>YK</given-names></string-name>, <string-name><surname>Friedman</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Fried</surname> <given-names>M</given-names></string-name>, <string-name><surname>Duffy</surname> <given-names>PE</given-names></string-name>, <string-name><surname>Kurtis</surname> <given-names>JD</given-names></string-name>. <year>2020</year>. <article-title>Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria</article-title>. <source>Nature</source> <volume>582</volume>:<fpage>104</fpage>–<lpage>108</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Raj</surname> <given-names>DK</given-names></string-name>, <string-name><surname>Nixon</surname> <given-names>CP</given-names></string-name>, <string-name><surname>Nixon</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Dvorin</surname> <given-names>JD</given-names></string-name>, <string-name><surname>DiPetrillo</surname> <given-names>CG</given-names></string-name>, <string-name><surname>Pond-Tor</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>H-W</given-names></string-name>, <string-name><surname>Jolly</surname> <given-names>G</given-names></string-name>, <string-name><surname>Pischel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>A</given-names></string-name>, <string-name><surname>Michelow</surname> <given-names>IC</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>L</given-names></string-name>, <string-name><surname>Conteh</surname> <given-names>S</given-names></string-name>, <string-name><surname>McDonald</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Absalon</surname> <given-names>S</given-names></string-name>, <string-name><surname>Holte</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Friedman</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Fried</surname> <given-names>M</given-names></string-name>, <string-name><surname>Duffy</surname> <given-names>PE</given-names></string-name>, <string-name><surname>Kurtis</surname> <given-names>JD</given-names></string-name>. <year>2014</year>. <article-title>Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection</article-title>. <source>Science</source> <volume>344</volume>:<fpage>871</fpage>–<lpage>877</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><collab>RTS,S Clinical Trials Partnership</collab>. <year>2015</year>. <article-title>Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial</article-title>. <source>Lancet</source> <volume>386</volume>:<fpage>31–45</fpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Sage</surname> <given-names>PT</given-names></string-name>, <string-name><surname>Alvarez</surname> <given-names>D</given-names></string-name>, <string-name><surname>Godec</surname> <given-names>J</given-names></string-name>, <string-name><surname>von Andrian</surname> <given-names>UH</given-names></string-name>, <string-name><surname>Sharpe</surname> <given-names>AH</given-names></string-name>. <year>2014</year>. <article-title>Circulating T follicular regulatory and helper cells have memory-like properties</article-title>. <source>J Clin Invest</source> <volume>124</volume>:<fpage>5191</fpage>–<lpage>5204</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Schmitt</surname> <given-names>N</given-names></string-name>, <string-name><surname>Bentebibel</surname> <given-names>S-E</given-names></string-name>, <string-name><surname>Ueno</surname> <given-names>H</given-names></string-name>. <year>2014</year>. <article-title>Phenotype and functions of memory Tfh cells in human blood</article-title>. <source>Trends Immunol</source> <volume>35</volume>:<fpage>436</fpage>–<lpage>442</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Seth</surname> <given-names>A</given-names></string-name>, <string-name><surname>Craft</surname> <given-names>J</given-names></string-name>. <year>2019</year>. <article-title>Spatial and functional heterogeneity of follicular helper T cells in autoimmunity</article-title>. <source>Curr Opin Immunol</source> <volume>61</volume>:<fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Stanisic</surname> <given-names>DI</given-names></string-name>, <string-name><surname>McCall</surname> <given-names>MBB</given-names></string-name>. <year>2021</year>. <article-title>Correlates of malaria vaccine efficacy</article-title>. <source>Expert Rev Vaccines</source> <volume>20</volume>:<fpage>143</fpage>–<lpage>161</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Tarlinton</surname> <given-names>D</given-names></string-name>, <string-name><surname>Good-Jacobson</surname> <given-names>K</given-names></string-name>. <year>2013</year>. <article-title>Diversity among memory B cells: origin, consequences, and utility</article-title>. <source>Science</source> <volume>341</volume>:<fpage>1205</fpage>–<lpage>1211</lpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Taylor</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Juliano</surname> <given-names>JJ</given-names></string-name>. <year>2014</year>. <article-title>Artemisinin combination therapies and malaria parasite drug resistance: the game is afoot</article-title>. <source>J Infect Dis</source>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Turnbull</surname> <given-names>LB</given-names></string-name>, <string-name><surname>Ayodo</surname> <given-names>G</given-names></string-name>, <string-name><surname>Knight</surname> <given-names>V</given-names></string-name>, <string-name><surname>John</surname> <given-names>CC</given-names></string-name>, <string-name><surname>McHenry</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Tran</surname> <given-names>TM</given-names></string-name>. <year>2022</year>. <article-title>Evaluation of an ultrasensitive HRP2-based rapid diagnostic test for detection of asymptomatic Plasmodium falciparum parasitaemia among children in western Kenya</article-title>. <source>Malar J</source> <volume>21</volume>:<fpage>337</fpage>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Wei</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Feng</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hou</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>XM</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>D</given-names></string-name>. <year>2015</year>. <article-title>Flow cytometric analysis of circulating follicular helper T (Tfh) and follicular regulatory T (Tfr) populations in human blood</article-title>. <source>Methods Mol Biol</source> <volume>1291</volume>:<fpage>199</fpage>–<lpage>207</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Wing</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Tekgüç</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sakaguchi</surname> <given-names>S</given-names></string-name>. <year>2018</year>. <article-title>Control of Germinal Center Responses by T-Follicular Regulatory Cells</article-title>. <source>Front Immunol</source> <volume>9</volume>:<fpage>1910</fpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Yman</surname> <given-names>V</given-names></string-name>, <string-name><surname>White</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Asghar</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sundling</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sondén</surname> <given-names>K</given-names></string-name>, <string-name><surname>Draper</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Osier</surname> <given-names>FHA</given-names></string-name>, <string-name><surname>Färnert</surname> <given-names>A</given-names></string-name>. <year>2019</year>. <article-title>Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure</article-title>. <source>BMC Med</source> <volume>17</volume>:<fpage>22</fpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Yu</surname> <given-names>D</given-names></string-name>, <string-name><surname>Rao</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tsai</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>SK</given-names></string-name>, <string-name><surname>He</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sutcliffe</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Srivastava</surname> <given-names>M</given-names></string-name>, <string-name><surname>Linterman</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>L</given-names></string-name>, <string-name><surname>Simpson</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ellyard</surname> <given-names>JI</given-names></string-name>, <string-name><surname>Parish</surname> <given-names>IA</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Q-J</given-names></string-name>, <string-name><surname>Parish</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Mackay</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Vinuesa</surname> <given-names>CG</given-names></string-name>. <year>2009</year>. <article-title>The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment</article-title>. <source>Immunity</source> <volume>31</volume>:<fpage>457</fpage>–<lpage>468</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname> <given-names>X</given-names></string-name>, <string-name><surname>Jin</surname> <given-names>T</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>C</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>D</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name>. <year>2020</year>. <article-title>Imbalance of Circulating Tfh/Tfr Cells in Patients With Parkinson’s Disease</article-title>. <source>Front Neurol</source> <volume>11</volume>:<fpage>572205</fpage>.</mixed-citation></ref>
</ref-list>
<sec id="d1e5737">
<title>Supplementals</title>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 1:</label>
<caption><title>Representative cytoplots of the extracellular flow staining.</title>
<p>Panel <bold>a</bold> shows the CXCR5 vs CD25 cytoplots on unfiltered, CD19<sup>pos</sup>, CD3<sup>pos</sup>, CD4<sup>pos</sup> and CD8<sup>pos</sup> cells from left to right. Panel <bold>b</bold> shows CD45RA vs CCR7 cytoplots on CD3<sup>pos</sup>, CD8<sup>pos</sup>, CD4<sup>pos</sup> and CD4<sup>pos</sup>CXCR5<sup>pos</sup> cells from left to right. Panel <bold>c</bold> shows CCR6 vs CXCR3 staining on CD4<sup>pos</sup>CXCR5<sup>pos</sup> cells. Panel <bold>d</bold> shows CD127 vs CD40L expression within CD4<sup>pos</sup>CXCR5<sup>pos</sup> cells by unstimulated and SEB stimulated cells. Panel <bold>e</bold> shows ICOS vs PD1 cytoplots after no stimulation or SEB 6h stimulation.</p></caption>
<graphic xlink:href="589352v1_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 2:</label>
<caption><title>EdgeR analysis of the CD4<sup>pos</sup>, CD4<sup>pos</sup>CXCR5<sup>pos</sup>, CD8<sup>pos</sup> and CD14/CD19<sup>pos</sup> populations under different stimulation conditions in adults (n=15) and children (n=14).</title>
<p>Volcano plot from EdgeR analysis comparing CD4<sup>pos</sup>, CD4<sup>pos</sup>CXCR5<sup>pos</sup>, CD8<sup>pos</sup>, and CD14/CD19<sup>pos</sup> populations from adult PBMCs under the following conditions: <bold>(a)</bold> unstimulated versus <italic>Pf</italic>SEA-1A, <bold>(b)</bold> unstimulated versus <italic>Pf</italic>GARP, and <bold>(c)</bold> <italic>Pf</italic>SEA-1A versus <italic>Pf</italic>GARP. Volcano plot from EdgeR analysis comparing CD4<sup>pos</sup>, CD4<sup>pos</sup>CXCR5<sup>pos</sup>, CD8<sup>pos</sup>,and CD14/CD19<sup>pos</sup> populations from children PBMCs under the following conditions: <bold>(d)</bold> unstimulated versus <italic>Pf</italic>SEA-1A, <bold>(e)</bold> unstimulated versus <italic>Pf</italic>GARP, and <bold>(f)</bold> <italic>Pf</italic>SEA-1A versus <italic>Pf</italic>GARP. The green dots are statistically significant whereas the black dots are not, here no green dots were observed.</p></caption>
<graphic xlink:href="589352v1_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 3:</label>
<caption><title>Characterization of T<sub>FH</sub> subsets using CXCR5, CXCR3, CCR6, and CD45RA expression.</title>
<p>Bar plots showing <bold>(a)</bold> CXCR5, <bold>(b)</bold> CD45RA, <bold>(c)</bold> CCR6, and <bold>(d)</bold> CXCR3 expression across all cT<sub>FH</sub>-like meta-clusters from adults (n=13) under no stimulation (blue), <italic>Pf</italic>GARP (green) and <italic>Pf</italic>SEA-1A (pink) stimulations. Fifty percent of the data are within the box limits, the solid line indicates the median, the dash line the mean and the whiskers indicate the range of the remaining data with outliers being outside that range.</p></caption>
<graphic xlink:href="589352v1_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 4:</label>
<caption><title>CCR6 versus CXCR3 representative cytoplots. a.</title>
<p>CCR6 vs CXCR3 expression from activated cT<sub>FH</sub>2-like MC01 (in blue), quiescent cT<sub>FH</sub>1-like MC07 (in pink), activated cT<sub>FH</sub>1/17-like MC11 (in orange) and activated cT<sub>FH</sub>17-like MC13 (in green). Undetermined meta-clusters was superposed to the sus-mentioned metacluster: activated cT<sub>FH</sub>1or2-like MC03 (in black) (<bold>b</bold>); activated cT<sub>FH</sub>1or2-like MC04 (in black) (<bold>c</bold>); quiescent cT<sub>FH</sub>1or2-like MC05 (in black) (<bold>d</bold>); quiescent cT<sub>FH</sub>1or2-like MC08 (in black) (<bold>e</bold>).</p></caption>
<graphic xlink:href="589352v1_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs5" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 5:</label>
<caption><title>Cartoon of T<sub>FH</sub> subsets and their state of activation.</title></caption>
<graphic xlink:href="589352v1_figs5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs6" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 6:</label>
<caption><title>State of activation of cT<sub>FH</sub> subsets from adults determined by PD1, ICOS, CCR7, and CD127.</title>
<p>Bar plots showing <bold>(a)</bold> PD1, <bold>(b)</bold> ICOS, <bold>(c)</bold> CCR7 and <bold>(d)</bold> CD127 expression across all cT<sub>FH</sub>-like meta-clusters in adults (n=13) under no stimulation (blue), <italic>Pf</italic>GARP (green) and <italic>Pf</italic>SEA-1A (pink) stimulations. Fifty percent of the data are within the box limits, the solid line indicates the median, the dash line the mean and the whiskers indicate the range of the remaining data with outliers being outside that range.</p></caption>
<graphic xlink:href="589352v1_figs6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs7" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 7:</label>
<caption><title>CD40L expression across stimulation and meta-clusters.</title>
<p>Dot plots of CD40L expression after manual gating based on unstimulated condition from children (n=13) (<bold>a</bold>) and adults (n=13) (<bold>b</bold>) cT<sub>FH</sub> meta-clusters.</p></caption>
<graphic xlink:href="589352v1_figs7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs8" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 8:</label>
<caption><title>Abundance of the cT<sub>FH</sub> meta-clusters within children with low or high levels of HRP2 antibodies.</title>
<p><bold>(a)</bold> UMAP plot showing the clustering of the 13 different cT<sub>FH</sub> meta-clusters (MC15) in children with low levels of HRP2 (on the left, n=6) and high levels of HRP2 (on the right, n=6) in the absence of stimulation. Each color represents a meta-cluster. The red circles highlight the meta-cluster showing differences in its abundance between the two groups of children. <bold>(b)</bold> An EdgeR statistical plot was performed to assess the abundance of the 13 meta-clusters between unstimulated PBMCs from both groups of children; the Y-axis being -log10(<italic>p</italic>-value) and the X-axis shows the log(FC). The green dot (MC04) is statistically significant whereas the black dots are not. <bold>(c)</bold> An abundance heatmap showing the distribution (in %) of each meta-cluster within the two groups of children (both concatenated unstimulated PBMCs from six participants). The color scale ranges from high abundance (red) to low abundance (blue).</p></caption>
<graphic xlink:href="589352v1_figs8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs9" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 9:</label>
<caption><title>Clustered heatmap of the cytokines and transcription factors expressed from cT<sub>FH</sub> meta-clusters in adults and children under the different stimulation conditions.</title>
<p>Heatmap of Bcl6, IFNγ, IL21, IL4, and cMAF expression from the 13 cT<sub>FH</sub> meta-clusters from concatenated data from <bold>(a)</bold> children (n=13) and <bold>(b)</bold> adults (n=13), after stimulation by <italic>Pf</italic>SEA-1A or <italic>Pf</italic>GARP, or without any stimulation as indicated in the name of each row. The color scale ranges from high expression (red) to low/no expression (blue).</p></caption>
<graphic xlink:href="589352v1_figs9.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs10" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 10:</label>
<caption><title>Bar plots of cytokines expressed under the different conditions of stimulation in children (n=13).</title>
<p>Comparison of mean fluorescent intensity (MFI) of <bold>(a)</bold> IFNγ, <bold>(b)</bold> IL4 cytokines expression after <italic>Pf</italic>SEA-1A (pink) or <italic>Pf</italic>GARP (green) stimulation or no stimulation control (blue). Bar plots indicate mean with SD. Wilcoxon-paired two-tailed t-tests were performed and <italic>p</italic>-values are indicated.</p></caption>
<graphic xlink:href="589352v1_figs10.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs11" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 11:</label>
<caption><title>Bar plots of transcription factors expressed under the different conditions of stimulation in children (n=13).</title>
<p>Comparison of mean fluorescent intensity (MFI) of <bold>(a)</bold> Bcl6 and <bold>(b)</bold> cMAF expression after <italic>Pf</italic>SEA-1A (pink) or <italic>Pf</italic>GARP (green) stimulation or no stimulation control (blue). Bar plots indicate mean with SD. Wilcoxon-paired two-tailed t-tests were performed and <italic>p</italic>-values are indicated.</p></caption>
<graphic xlink:href="589352v1_figs11.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs12" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 12:</label>
<caption><title>Bar plots of cytokines expressed under the different conditions of stimulation in adults (n=13).</title>
<p>Comparison of mean fluorescent intensity (MFI) of <bold>(a)</bold> IFNγ, <bold>(b)</bold> IL4 and <bold>(c)</bold> IL21 and cytokines expression after <italic>Pf</italic>SEA-1A (pink) or <italic>Pf</italic>GARP (green) stimulation or no stimulation control (blue). Bar plots indicate mean with SD. Wilcoxon-paired two-tailed t-tests were performed and <italic>p</italic>-values are indicated.</p></caption>
<graphic xlink:href="589352v1_figs12.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs13" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 13:</label>
<caption><title>Bar plots of transcription factors expressed under the different conditions of stimulation in adults (n=13).</title>
<p>Comparison of mean fluorescent intensity (MFI) of <bold>(a)</bold> Bcl6 and <bold>(b)</bold> cMAF expression after <italic>Pf</italic>SEA-1A (pink) or <italic>Pf</italic>GARP (green) stimulation or no stimulation control (blue). Bar plots indicate mean with SD. Wilcoxon-paired two-tailed t-tests were performed and <italic>p</italic>-values are indicated.</p></caption>
<graphic xlink:href="589352v1_figs13.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.98462.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Krzych</surname>
<given-names>Urszula</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Walter Reed Army Institute of Research</institution>
</institution-wrap>
<city>Silver Spring</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Useful</kwd>
</kwd-group>
</front-stub>
<body>
<p>Using multiparameter spectral flow cytometry and unbiased clustering analysis, this study provides <bold>useful</bold> insights into the heterogeneity of antigens-specific circulating T follicular helper cells from children and adults living in malaria-endemic areas of Kenya. Although the study is well-designed, the analysis and interpretation of the potential functional roles for PfSEA-1A- and PfGARP-specific subsets of circulating T follicular helper cells are <bold>incomplete</bold>.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.98462.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This study aims to understand the malaria antigen-specific cTfh profile of children and adults living in a malaria holoendemic area. PBMC samples from children and adults were unstimulated or stimulated with PfSEA-1A or PfGARP in vitro for 6h and analysed by a cTfh-focused panel. Unsupervised clustering and analysis on cTfh were performed.</p>
<p>The main conclusions are:</p>
<p>
(1) the cohort of children has more diverse (cTfh1/2/17) recall responses compared to the cohort of adults (mainly cTfh17) and</p>
<p>
(2) Pf-GARP stimulates better cTfh17 responses in adults, thus a promising vaccine candidate.</p>
<p>Strengths:</p>
<p>This study is in general well-designed and with excellent data analysis. The use of unsupervised clustering is a nice attempt to understand the heterogeneity of cTfh cells. Figure 9 is a beautiful summary of the findings.</p>
<p>Weaknesses:</p>
<p>(1) Most of my concerns are related to using PfSEA-1A and PfGARP to analyse cTfh in vitro stimulation response. In vitro, stimulation on cTfh cells has been frequently used (e.g. Dan et al, PMID: 27342848), usually by antigen stimulation for 9h and analysed CD69/CD40L expression, or 18h and CD25/OX40. However, the authors use a different strategy that has not been validated to analyse in vitro stimulated cTfh. Also, they excluded CD25+ cells which might be activated cTfh. I am concerned about whether the conclusions based on these results are reliable.</p>
<p>It has been shown that cTfh cells can hardly produce cytokines by Dan et al. However, in this paper, the authors report the significant secretion of IL-4 and IFNg on some cTfh clusters after 6h stimulation. If the stimulation is antigen-specific through TCR, why cTfh1 cells upregulate IL-4 but not IFNg in Figure 6? I believe including the representative FACS plots of IL-4, IFNg, IL21 staining, and using %positive rather than MFI can make the conclusion more convincing. Similarly, the author should validate whether TCR stimulation under their system for 6h can induce robust BCL6/cMAF expression in cTfh cells. Moreover, there is no CD40L expression. Does this mean TCR stimulation mediated BCl6/cMAF upregulation and cytokine secretion precede CD40L expression?</p>
<p>In summary, I am particularly concerned about the method used to analyse PfSEA-1A and PfGARP-specific cTfh responses because it lacks proper validation. I am unsure if the conclusions related to PfSEA-1A/PfGARP-specific responses are reliable.</p>
<p>(2) The section between lines 246-269 is confusing. Line 249, comparing the abundance after antigen stimulation is improper because 6h stimulation (under Golgi stop) should not induce cell division. I think the major conclusions are contained in Figure 5e, that (A) antigen stimulation will not alter cell number in each cluster and (B) children have more MC03, 06 and fewer MC02, etc.). The authors should consider removing statements between lines 255-259 because the trends are the same regardless of stimulations.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.98462.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Forconi et al explore the heterogeneity of circulating Tfh cell responses in children and adults from malaria-endemic Kenya, and further compare such differences following stimulation with two malaria antigens. In particular, the authors also raised an important consideration for the study of Tfh cells in general, which is the hidden diversity that may exist within the current 'standard' gating strategies for these cells. The utility of multiparametric flow cytometry as well as unbiased clustering analysis provides a potentially potent methodology for exploring this hidden depth. However, the current state of analysis presented does not aid the understanding of this heterogeneity. This main goal of the study could hopefully be achieved by putting all the parameters used in one context, before dissecting such differences into their specific clinical contexts.</p>
<p>Strengths:</p>
<p>Understanding the full heterogeneity of Tfh cells in the context of infection is an important topic of interest to the community. The study included clinical groupings such as age group differences and differences in response to different malaria antigens to further highlight context-dependent heterogeneity, which offers new knowledge to the field. However, improvements in data analyses and presentation strategies should be made in order to fully utilize the potential of this study.</p>
<p>Weaknesses:</p>
<p>In general, most studies using multiparameter analysis coupled with an unbiased grouping/clustering approach aim to describe differences between all the parameters used for defining groupings, prior to exploring differences between these groupings in specific contexts. However, the authors have opted to separate these into sections using &quot;subset chemokine markers&quot;, &quot;surface activation markers&quot; and then &quot;cytokine responses&quot;, yet nuances within all three of these major groups were taken into account when defining the various Tfh identities. Thus, it would make sense to show how all of these parameters are associated with one another within one specific context to first logically establish to the readers how can we better define Tfh heterogeneity. When presented this way, some of the identities such as those that are less clear such as &quot;MC03/MC04/ MC05/ MC08&quot; may even be better revealed. once established, all of these clusters can then be subsequently explored in further detail to understand cluster-specific differences in children vs adults, and in the various stimulation conditions. Since the authors also showed that many of the activation markers were not significantly altered post-stimulation thus there is no real obstacle for merging the entire dataset for the first part of this study which is to define Tfh heterogeneity in an unbiased manner regardless of age groups or stimulation conditions. Other studies using similar approaches such as Mathew et al 2020 (doi: 10.1126/science.abc8) or Orecchioni et al 2017 (doi: 10.1038/s41467-017-01015-3) can be referred to for more effective data presentation strategies.</p>
<p>Accordingly, the expression of cytokines and transcription factors can only be reliably detected following stimulation. However, the underlying background responses need to be taken into account for understanding &quot;true&quot; positive signals. The only raw data for this was shown in the form of of heatmap where no proper ordering was given to ensure that readers can easily interpret the expression of these markers following stimulation relative to no stimulation. Thus, it is difficult to reliably interpret any real differences reported without this. Finally, the authors report differences in either cluster abundance or cluster-specific cytokine/ transcription factor expression in Tfh cell subsets when comparing children vs adults, and between the two malaria antigens. The comparisons of cytokine/transcription factor between groups will be more clearly highlighted by appropriately combining groupings rather than keeping them separate as in Figures 6 and 7.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.98462.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The goal of this study was to carry out an in-depth granular and unbiased phenotyping of peripheral blood circulating Tfh specific to two malaria vaccine candidates, PfSEA-1A and PfGARP, and correlate these with age (children vs adults) and protection from malaria (antibody titers against Plasmodium antigens.). The authors further attempted to identify any specific differences in the Tfh responses to these two distinct malaria antigens.</p>
<p>Strengths:</p>
<p>The authors had access to peripheral blood samples from children and adults living in a malaria-endemic region of Kenya. The authors studied these samples using in vitro restimulation in the presence of specific malaria antigens. The authors generated a very rich data set from these valuable samples using cutting-edge spectral flow cytometry and a 21-plex panel that included a variety of surface markers, cytokines, and transcription factors.</p>
<p>Weaknesses:</p>
<p>- Quantifying antigen-specific T cells by flow cytometry requires the use of either 1- tetramers or 2- in vitro restimulation with specific antigens followed by identification of TCR-activated cells based on de-novo expression of activation markers (e.g. intracellular cytokine staining and/or surface marker staining). Although authors use an in vitro restimulation strategy, they do not focus their study on cells de-novo expressing activation markers as a result of restimulation; therefore, their study is not really on antigen-specific cTfh. Moreover, the authors report no changes in the expression of activation markers commonly used to identify antigen-specific T cells upon in vitro restimulation (including IFNg and CD40L); therefore, it is not clear if their in vitro restimulation with malaria antigens actually worked.</p>
<p>- CXCR5+CD4+ memory T cells have been shown to present multi-potency and plasticity, capable of differentiating to non-Tfh subsets upon re-challenge. Although authors included in their flow panel a good number of markers commonly used in combination to identify Tfh (CXCR5, PD-1, ICOS, Bcl-6, IL-21), they only used one single marker (CXCR5) as their basis to define Tfh, thus providing a weak definition for Tfh cells and follow up downstream analysis.</p>
<p>- Previous works have used FACS-sorting and in vitro assays for cytokine production and B cell help to study the functional capacity of different cTfh subsets in blood from Plasmodium-infected individuals. In this study, authors do not carry out any such assays to isolate and evaluate the functional capacity of the different Tfh subsets identified. Thus, all the suggestions for the role that these different cTfh subsets may have in vivo in the context of malaria remain highly hypothetical.</p>
<p>- The authors have not included malaria unexposed control groups in their study, and experimental groups are relatively small (n=13).</p>
</body>
</sub-article>
</article>